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Abstract 
 
 
Phenotypic Characterization of PNPase Mutation and Overexpression in C. elegans 
 
By Brian Hur, B.S. 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science 
at Virginia Commonwealth University  
 
Virginia Commonwealth University, 2019 
 
Major Director: Rita Shiang 
Associate Professor, Department of Human and Molecular Genetics  
 
PNPase, polynucleotide phosphorylase, is a multifunctional exoribonuclease protein with 3` 
terminal oligonucleotide polymerase activity. Coded by the PNPT1 gene, the protein is 
associated with mitochondrial homeostasis and functions as a possible target for cancer therapy.   
In this study, C. elegans was used to investigate the effect of mutation and overexpression of 
pnpt-1, the gene that encodes PNPase.  It was determined that two specific mutations in pnpt-1 
did not affect PNPase expression nor did they produce deleterious phenotypes that affected 
polycistronic transcript accumulation or ROS production.  Creation of a stable overexpression 
model was achieved through Fusion PCR.  However, different transgenic strains overexpressing 
PNPase produced opposite results for polycistronic transcript accumulation while ROS 
production saw no significant change, suggesting a mosaic overexpression model.   
In a cancer model, exogenous PNPase was present in the pachytene region of the germline and 
where expressed the cells were in non-germline cells suggesting differentiation mechanisms 
associated with overexpression of PNPase.  However, further analysis of different mutations in 
pnpt-1 or optimizations to the overexpression model are necessary to provide a better 
understanding of PNPase function with mitochondria homeostasis and in a cancer model setting. 
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Chapter 1: Introduction 
 
I. PNPase 
 
Encoded by the PNPT1 (polyribonucleotide nucleotidyltransferase 1), PNPase is an 
evolutionarily conserved 3`-5` phosphate dependent exoribonuclease and 5`-3` RNA polymerase 
that adds poly(A) tails to RNA molecules (Sarkar et. al., 2005; Das et. al., 2010).  The protein 
localizes either in the inter membrane space of the mitochondria or the cytosol (Piwowarski et. 
al., 2003).  In humans, the PNPT1 gene is located within 2p15-2p16.1 and spans 60 kb, 
consisting of 28 exons (Leszczyniecka et. al., 2003).  During a screen between terminally 
differentiated HO-1 melanoma cells and senescent progeroid fibroblasts to identify co-regulated 
genes, 75 genes were classified and labeled as old-1 through old-75.  Among the 75 genes, old-
35 presented significant sequence similarity to PNPase from other species, thus cataloguing 
human PNPase as hPNPase old-35 (Leszczyniecka et. al., 2002). 
Functioning as an exoribonuclease, PNPase selectively degrades specific targets such as 
c-myc mRNA, miR-221, miR-222, miR-106b, and other miRNAs involved in oncogenesis in the 
cytosol. (Sarkar et. al., 2003; Das et. al., 2010).  PNPase also regulates translocation of small 
RNA molecules into the mitochondria such as MRP (mitochondria RNA processing) RNA, 
RNase P, and 5S rRNA (Wang et. al., 2010).  Additionally, PNPase has been found to be 
induced by type I interferons, specifically IFN-alpha and beta.  Studies identified an ISRE, IFN-
stimulated response element, in the promoter of hPNPase old-35.  Mutations in this site 
eliminated induction of gene expression (Leszcyzyniecka et. al., 2003). 
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II. PNPase Structure 
 
 PNPase is conserved across most organisms from simple species of bacteria to complex 
and higher mammals, with the exception of yeast (Leszczyniecka et. al., 2004).  The protein is 
comprised of four major domains that include two RNase PH domains, one KH domain, and one 
S1 domain.  Spatially, the two catalytic RNase PH domains are located towards the N-terminal 
end while the RNA-binding KH and S1 domains are located closer to the C-terminus (Figure 1A) 
(Leszczyniecka et. al., 2004).    In humans, PNPase is a large molecule that consists of 738 
amino acids with an alpha helix to separate the two RNase PH domains (Leszczyniecka et. al., 
2002).  Despite the presence of conserved domains of PNPase, there are variations of the protein 
structure within different organisms.  PNPase in plants contains an N-terminal target peptide for 
translocation of the protein to the chloroplast while the animal variant has a N-terminal 
mitochondrial localization signal to direct the protein to the intermembrane space of the 
mitochondria (Piwowarski et. al., 2003; Sarkar et al., 2005).   
 On a structural level, PNPase forms a homotrimeric structure or a dimer of homotrimers 
resulting in a doughnut-like shape (Figure 1B) (Carpousis et. al., 2002).  The RNase PH domains 
create a channel for catalytic activity for single-stranded RNA molecules (Symmons et. al,. 2000: 
Symmons et. al., 2002).  Superior to the RNase PH domains are the KH and S1 domains that also 
contribute to central channel structure but primarily function as RNA-binding domains 
(Golzarroshan et. al.,2018).  Catalytic activity from the RNase PH domains varies in different 
organisms.  In a review, the catalytic activity of PNPase in bacteria is primarily carried out by 
the second RNase PH domain while the RNase PH domains in plants contribute equally (Sarkar 
and Fisher, 2006).  For human PNPase, mutational analysis has determined that both RNase PH 
domains have equal catalytic activity and the presence of at least one RNase PH domain is 
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adequate for complete enzymatic activity (Sarkar et. al., 2005).  The KH and S1 domains are also 
vital to protein function.  Deletion of the S1 or KH domains results in a decrease in enzymatic 
activity by 50 fold and 19 fold, respectively, while deletion of both domains results in 1% of 
enzymatic activity (Stickney et. al., 2005)     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1A: Protein motifs of PNPase. Both RNase PH, KH, and S1 domains are conserved 
across several organisms.  PNPase in different organisms contain variations in the N-terminal 
targeting sequence/peptide or no targeting sequence/peptide at all. (Sohki et. al., 2013) 
 
 
 
 
Figure 1B: Structure of PNPase. PNPase assembles into a homotrimer revealing a donut-like 
structure with a channel in the middle where catalytic activity takes place. (Shi et. al., 2008) 
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III. PNPase Localization 
 
 Human PNPase is mainly localized within the intermembrane space of the mitochondria 
(Piwowarski et. al., 2003).  The N-terminal mitochondrial targeting sequence (MTS) of the 
protein directs it to the organelle (Chen et. al., 2006).  PNPase is then imported through the TOM 
and TIM23 pores of the mitochondria where it is cleaved by MPP (mitochondrial processing 
peptidase) at the region following the N-terminal targeting sequence.  Yme1 serves as a 
translocation motor that pulls PNPase into the intermembrane space where PNPase assembles 
into the final multimeric complex (Figure 2) (Rainey et. al., 2006).  Cleavage of the N-terminal 
targeting sequence by MPP exposes a hydrophobic region on PNPase that is hypothesized to 
serve as a stop-transfer domain to stop translocation through TIM23 (Rainey et. al., 2006).  
 Depending on the organism, PNPase localizes in different regions.  In plants, PNPase 
localizes in the chloroplast stroma and functions as a poly(A) polymerase and exoribonuclease 
(Chen et. al., 2006).  Outside of plants and in multiple cell types, PNPase is found in the 
intermembrane space of the mitochondria, regulating mtRNA levels (Chen et. al., 2006; 
Piwowarski et. al., 2003).  Other studies have also noted that hPNPase can localize in the 
cytoplasm where it degrades specific mRNA and miRNA molecules. (Leszczyniecka et. al., 
2002; Sarker et. al., 2003; Das et. al., 2010). 
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Figure 2: Localization of PNPase in the mitochondria.  Mechanism of PNPase localization in 
the intermembrane space of the mitochondria through the Yme1 complex and MPP. (Rainey et. 
al., 2006) 
 
 
IV. Functional Studies – Mouse Knockout and Cellular Knockdown 
 
 Previous in vivo mouse studies had attempted knocking out PNPase but were 
unsuccessful since it was determined that embryos without PNPase were nonviable and 
embryonic lethal (Wang et. al., 2010).  Instead, a conditional liver knockout of PNPase was 
produced in a mouse model.  Knockout of PNPase in liver cells resulted in disrupted respiration 
and mitochondrial morphology with mitochondria cristae appearing disordered, circular, and 
smooth (Wang et. al., 2010).  Inhibition of mitochondrial RNA transport which regulate the 
transcription and translation of electron transport chain proteins partially contributed to the 
disrupted respiration mechanisms (Wang et. al., 2010).   
PNPase knockdown was also performed in melanoma cell line HEK-293T (Chen et. al., 
2006).  Results included impairment of the respiratory chain complex with a decrease in 
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enzymatic activity, mitochondria appearing filamentous and granular, and decrease in complex 3 
and 4 potential of the respiratory chain complex (Chen et. al., 2006).  All of this contributed to a 
decrease in cell growth with increased cell death (Chen et. al, 2006). 
 
V. Functional Studies – Cellular Overexpression 
 
 Overexpression of hPNPase old-35 was studied in HO-1 cells with two different 
approaches to analyze growth suppression mechanisms: slow and sustained overexpression with 
low multiplicity of adenoviral vector and rapid overexpression with a high multiplicity of an 
adenoviral vector (Sarkar et. al., 2003).  Each overexpression mechanism produced different 
results.  Slow and sustained overexpression resulted in an induction of a senescent-like 
phenotype and growth inhibition (Sarkar et. al., 2003).  Infected HO-1 cells arrested in the G1 
phase of the cell cycle with a reduction of cells in the S phase that eventually lead to apoptosis 
(Sarkar et. al., 2003; van Maerken et. al., 2009).  Rapid overexpression of PNPase resulted in 
induced growth arrest and promotion of apoptosis without any changes to the cell cycle (Sarkar 
et. al., 2003).   
Overexpression of PNPase also decreased expression of c-myc mRNA and Myc protein, 
a transcription factor that regulates cell growth (Sarkar et. al., 2003).  hPNPase old-35 selectively 
degraded c-myc RNA molecules through recognition of the 3` UTR, which led to blocked 
mitogenic signals and cells driven to terminal differentiation (Sarkar et. al., 2003; Sarkar et al 
2006).  Other effects of overexpressing hPNPase included inhibition of DNA synthesis and 
telomerase activity, and up regulation of CDKI p27KIP1 (Sarkar et. al., 2005).  All of these 
factors contributed to the senescent-like phenotype associated with overexpression of hPNPase 
old-35 (Sarkar et. al., 2003; Sarkar et. al., 2005).   
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Overexpressed hPNPase old-35 also targets and degrades other RNA molecules such as 
miR-221, miR-222, and miR-106b (Das et. al., 2009).  miR-221 is often upregulated in various 
human cancers including glioblastoma, liver, bladder, thyroid, pancreatic, gastric and prostate 
carcinomas (Lupini et. al., 2013).  miR-222 is also upregulated in several cancer types, targeting 
MMP1 (metal metallic protease 1) and SOD2 (superoxide dismutase 2) (Liu et. al., 2009).  miR-
106b targets several tumor suppressor genes (Liu et. al., 2014).  In a comparison with normal 
cells, tumorigenic cells presented down-regulated expression of hPNPase old-35, allowing 
upregulation of oncogenic miRNA molecules to facilitate tumorigenesis (Das et. al., 2009).  The 
correlation between miRNA targets of hPNPase and cancer progression makes overexpression of 
hPNPase old-35 an appealing anti-cancer approach.   
 
VI. PNPase in the Mitochondria 
Due to the localization of hPNPase old-35 in the intermembrane space of the 
mitochondria, several studies investigated if hPNPase-old 35 has a role in mitochondrial 
homeostasis.  Overexpressing hPNPase old-35 resulted in an increase in reactive oxygen specie 
(ROS) production (Sarkar et. al., 2004).  Increase in ROS production led to an increased 
activation of the NF-kB pathway and the downstream genes associated with proinflammatory 
cytokine synthesis (Sarkar et. al., 2004).  Ultimately, overexpression of hPNPase old-35 induced 
a senescent-like growth arrest phenotype with increased production of ROS contributing to 
irreversible growth arrest of the cell (Sarkar et. al., 2004).  Knockdown studies in HEK293T 
cells that decreased expression of hPNPase old-35 resulted in mitochondrial dysfunction (Chen 
et. al., 2006).  Mitochondria appeared to be fragmented, filamentous, and granular shaped with 
decreased membrane potential (Chen et. al., 2006).  At the enzymatic level, coupled respiratory 
complexes I/III, and II/III presented reduced enzymatic activity with dysfunction in complex I of 
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the electron transport chain, resulting in elevated lactate and decreased ATP levels (Chen et. al., 
2006).  
hPNPase old-35 also functions as an importer trafficking small RNA molecules into the 
mitochondria, specifically RNase P RNA, MRP RNA, and 5S RNA (Wang et. al., 2012).  RNase 
P is an endoribonuclease that processes mitochondrial tRNAs.  MRP RNA is a site-specific 
endonuclease that processes mtRNA transcripts to form primers to initiate replication of mtDNA.  
5S rRNA is a ribosomal component that provides regulatory interactions among the functional 
sites of the translating protein (Wang et. al., 2012). The figure below displays the various roles 
PNPase plays within the cell at different locations (Figure 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Roles and subcellular localization of PNPase.  PNPase in the cytoplasm functions in 
miRNA and c-myc degradation.  Upon entry into the mitochondria through the TOM/TIM 
complex, PNPase mechanisms associate with ROS production, mtRNA processing, RNA 
polymerization, and RNA import into the organelle. (Sohki et. al., 2013) 
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VII. Human Diseases 
 
In a clinical setting, mutations in PNPase have been associated with myopathy, 
encephalopathy, and neuropathy (Vedrenne et. al., 2012) and human hereditary hearing loss (von 
Ameln et. al., 2012).  These studies highlight PNPase’s connection with mitochondrial function 
and homeostasis.  In the first study, two siblings of consanguineous parents presented with a 
homozygous missense mutation in the second RNase PH catalytic domain of PNPT1 (c. 1160 
A>G)(Q387R).  In the first child, there was a significant decrease in 5S rRNA and MRP RNA 
import into the mitochondria and decreased rate of mitochondrial translation.  The child had slow 
voluntary movements, dystonia, dyskinesia, choreoathetosis, global hypotonia, severe muscle 
weakness, and no head control. Due to muscle atrophy, deep tendon reflexes were barely 
detected.  The second child developed motor regression with trunk hypotonia, choreoathetotic 
movements, major dystonia in the limbs, and global hypotonia.  Overall, the two children had 
fixed but nonprogressive encephalopathy with mildly elevated levels of lactate in the plasma and 
cerebrospinal fluid.  On a molecular level, there was decreased activity of respiratory chain 
complexes III and IV in the liver in the first child.  The second child presented normal enzymatic 
activity in both skeletal muscle samples and cultured skin fibroblasts (Vedrenne et. al., 2012).  
The results above provided strong evidence of the role of PNPase in RNA import into the 
mitochondria and maintenance of a functional respiratory chain complex (Vedrenne et. al., 
2012).  
The second study consisted of 3 siblings from a consanguineous family that presented 
with severe hearing impairment.  Sequence analysis identified a missense mutation in the second 
RNase PH catalytic PNPT1 (c. 1424 A>G)(E475G) in the second RNase-PH domain.  The 
missense mutation interfered with oligomerization and prevented PNPase from properly forming 
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a homotrimer, but the protein was able to behave as a hypomorph.  Trimerization was reduced 
with increased monomer formation that had decreased protein function.   As a result, a decrease 
of RNase P RNA import into the mitochondria was observed.  Due to the high energy demand of 
the inner ear, it was hypothesized that the slower rate of import of small RNA molecules of the 
PNPase hypomorph negatively affected the inner ear tissue and not others.  Variation of 
phenotypes observed between the two families led researchers to hypothesize that the different 
functional deficits of PNPase was dependent on the severity of the mutation (von Ameln et. al., 
2012). 
A third human study identified two siblings from a non-consanguineous family that 
presented disease phenotypes which included severe axonal neuropathy, optic atrophy, 
intellectual disability, auditory neuropathy and chronic respiratory and gut disturbances (Alodaib 
et. al., 2016).  Unlike the previous studies, whole exome sequencing on all family members 
identified compound heterozygous missense variants in the PNPT1 gene in the two affected 
siblings with mutations Q254K in the first catalytic RNase PH domain and A510P in the second 
RNase PH domain that were predicted to be damaging (Alodaib et. al., 2016).  In patient 
fibroblasts, the missense mutations affected quaternary formation of PNPase protein and 
presented a reduction in protein and mRNA expression of PNPT1 when compared to samples 
from unaffected family members.  However, mRNA expression of PNPT1 did not vary in blood 
samples from unaffected and affected family members.  Analysis of the oxidative 
phosphorylation complexes identified significant reduction of expression with complex I, III, and 
IV and decreased enzymatic activity of complex I and IV in the patient fibroblasts.  The study 
also confirmed impairment of mitochondrial translation with a 33% reduction in total 
mitochondrial protein synthesis in comparison to the unaffected control (Alodaib et. al., 2016).  
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 Another study observed the effects of the disease-causing missense mutations, Q387R 
and E475G, in the second RNase PH catalytic domain of PNPase on a proteomic and molecular 
level using Escherichia coli.  As a result of the mutations, PNPase formed dimers rather than 
trimers and had significantly lower RNA binding and degradation activities compared to wild-
type trimeric PNPase (Golzarroshan et. al., 2018).  Specifically, human PNPase mutants formed 
a dimeric structure with a disrupted KH pore that impeded ssRNA binding.  Analysis of the KH 
pore in trimeric PNPase identified exposed GXXG motifs within the KH domain oriented inward 
toward the pore.  This positioning of GXXG motifs facilitated interactions with and binding to 
ssRNA (Golzarroshan et. al., 2018).  However, the dimeric mutant PNPase presented a disrupted 
KH pore with GXXG motifs located far apart, making them less available for RNA binding and 
interaction (Figure 4).  These findings explained the decreased ssRNA binding and degrading 
activity in mutant dimeric PNPase compared to trimeric PNPase (Golzarroshan et. al., 2018).  
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Figure 4: Wildtype vs Mutant PNPase. (A) Wildtype PNPase trimer forms a donut-like shape 
with GXXG motifs of KH domains located close to each to other at the KH pore. (B) Mutant 
PNPase that resulted in a dimeric protein with KH domains distant from each other. 
(Golzarroshan et al., 2018) 
 
 
VIII. ROS 
 
 ROS, products of cellular respiration, are synthesized when molecular oxygen (O2) is 
reduced.  Such species include hydrogen peroxide, hydroxyl radical, and superoxide.  Within the 
mitochondrial electron transport chain, Complex I and Complex III are responsible for the 
synthesis and release of superoxides into the intermembrane space of the mitochondria.  Sizeable 
accumulations of ROS within the cell damages proteins, lipids, and DNA.  However, low 
amounts of ROS molecules can serve as activators for signaling pathways associated with 
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proliferation and transcription (Trachootham et. al., 2008; Droge et. al., 2002; Thannickal et. al., 
2000).  Studies have proven that slight increases in ROS activate beneficial stress responses that 
lead to lifespan extension rather than producing harmful effects (Zarse et. al., 2012; Schulz et. 
al., 2007).  To offset the accumulation and effect of superoxides, superoxide dismutase converts 
superoxide into hydrogen peroxide.  The hydrogen peroxide is then eliminated by other 
peroxiredoxins and peroxidases (Sena and Chandel, 2012).   
 
IX. C. elegans 
 
Caenorhabditis elegans is a free living nematode that is used as a popular model 
organism for studies of developmental biology and basic functions and mechanisms of 
eukaryotic cells (Corsi et. al., 2015).  Championed by Syndey Brenner, this specific nematode 
species proves to be a valuable model to study mutations that contribute to human diseases.  The 
animal exists mostly as self-fertilizing hermaphrodites with a genotype of XX for sex 
chromosomes.  Male C. elegans are present but arise at a low frequency of <0.2% with a XO 
genotype (Corsi et. al., 2015).  Their self-fertilizing nature allows stocks to be maintained from a 
single animal, giving rise to an entire population.  
C. elegans is an attractive model due to a short three day life cycle to develop from an 
egg to a 1 millimeter long egg-laying adult, small size, complete sequenced genome, and ease of 
growth and maintenance.  Their transparent body throughout their life cycle allows easy 
examination of cells with differential interference contrast (DIC) microscopy (Corsi et. al., 
2015).  Due to their simple nature, the nematode is an optimal system to investigate the genetics 
of basic behavior mechanisms such as foraging, feeding, defecation, movement, egg laying, 
sensory responses to touch, smell, and other simple forms of behavior (Rankin et. al., 2002).  
However, there are limitations that prevent C. elegans from being the perfect model organism. 
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Such as lacking specialized tissues found in higher organisms (Van Raamsdonk and Hekimi, 
2010).  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Anatomy of C. elegans hermaphrodite body 
(https://en.wikipedia.org/wiki/Caenorhabditis_elegans#/media/File:Caenorhabditis_elegans_her
maphrodite_adult-en.svg) 
 
 
X. PNPase in C. elegans 
 
 In C. elegans, the ortholog for PNPT1 is pnpt-1 and consists of 10 exons located on 
chromosome III.  The pnpt-1 transcript was initially identified during an RNA interference 
(RNAi) profiling of embryogenesis (Sonnichsen et. al., 2005). tm1909, a deletion mutant, 
resulted in lethal and sterile phenotypes.  However, this deletion mutant was not limited to pnpt-
1 and included a neighboring upstream gene, chin-1.    
 C. elegans proved to be the ideal model for this project due to ease of gene expression 
manipulation through RNAi, a molecular process where dsRNA inhibits gene expression or 
translation, for knockdown analysis, ectopic expression through transgenic overexpression 
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analysis, the availability of mutant strains from the Caenorhabditis Genetics Center (CGC) for 
mutant analysis, and the ease and varied approaches at producing a cancer model.  Since 
previous attempts to produce a knockout model in other organisms were met with little success 
due to embryonic lethality (Wang et. al., 2010), and with no documentation of an overexpression 
animal model present, using C. elegans will provide a foundational understanding of the 
phenotypic effects of varied PNPase expression and observation of the senescent induced 
phenotype associated with overexpression of PNPase in a cancer model setting.   
 
XI. C. elegans Germline 
 
Germline development of C. elegans can be organized into three distinct phases: 
specification, growth, and maintenance (Figure 5A).  During early embryogenesis, P blastomeres 
are distinguished from somatic cells with the germline founder cell, P4, giving rise to only germ 
cells with no contribution to the soma.  P granules are segregated into the P blastomeres, 
contributing to germline development.  During the hatching stages of the nematode, the gonad 
consists to two primordial germ cells, Z2 and Z3, flanked by two somatic gonad precursors, Z1 
and Z4.  During the first two larval stages, the somatic gonad precursors divide to initially 
produce 12 cells, ten of which rearrange into somatic gonad primordium while the other two 
form the distal tip cells.  During the L3 stage, both gonad arms extend concurrently with 
proliferation of the germ line.  The L4 stage is identified by four-fold growth of germ cell 
number with germ cell proliferation in the distal mitotic zone (Hubbard et. al., 2005).  Entry from 
the mitotic zone into meiotic division at the proximal end of the gonad requires coordination of 
GLD-1, GLD-2, FBF-1/2, and NOS-3 signaling (Figure 5B) (Nayak et. al., 2004).  Within the 
transition zone between the mitotic and meiotic zones, chromosomes pair and undergo meiotic 
recombination until the pachytene stage.  Upon entry into the meiotic zone, homologous 
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recombination and formation of synaptonemal complexes occur with germ cell chromosomes.  
Mitogen activated protein kinase (MAPK) signaling in the germline allows progression from 
pachytene to diplotene.  From diplotene to diakineses, meiotic chromosomes become highly 
condensed and form six discrete oocyte bivalents (Hubbard et. al., 2005).   
Gametogenesis varies depending on the age of the nematode.  The late L4 stage is 
marked by spermatogenesis while the adult stage is marked by oogenesis (Hubbard et. al., 2005).  
During L4, GLD-1 and FOG-2 work together to inhibit tra-2 activity allowing fem-3 to be active 
and promote spermatogenesis.  When entering the adult stage, gld-1 and fog-2 are inactive, 
increasing tra-2 activity that causes repression of fem-3 function and switching the germline to 
oogenesis (Figure 5B) (Nayak et. al., 2004).  Ultimately, gonads of hermaphroditic C. elegans 
consist of a linear sequence of germ cells in different developmental stages (Ciosk et. al., 2006).   
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Figure 6A: Development of the C. elegans germline.  (A). Development of the germline 
founder cell (P4) and its associated primordial germ cells, Z2 and Z3, from the zygote stage of 
the nematode.  (B). Gonad formation and growth at different stages of nematode development.  
Red cells represent the distal tip cells.  Yellow represents the mitotic region.  Light green 
represents the transition phase consisting of early prophase of meiosis I.  Dark green represents 
pachytene.  Pink represents oogenesis.  Blue sheath represents the spermatheca precursor cells.  
Light blue sheath represents nuclei.  Grey represents the spermatheca.  White represents the 
uterus.  (Hubbard et. al., 2005) 
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Figure 6B: Genes involved in gametogenesis. (a) Interactions between several factors that 
regulate the switch between spermatogenesis and oogenesis. (b) Schematic of fog-2 and gld-1 
inhibition on tra-2 mRNA, allowing spermatogenesis. (Nayak et. al., 2004) 
 
 
XII. gld-1 Cancer Model in C. elegans  
 
 Several factors allow C. elegans to be useful for cancer research.  The model is 
completely characterized with an invariant somatic cell lineage allowing ease of identification of 
phenotypes that disrupt normal proliferation and patterning (Sulston and Horvitz, 1977; Sulston 
et. al., 1983).  The animal’s transparent body throughout its entire lifespan allows cells to be 
visualized during their division and movement.  Finally, many human genes and pathways 
associated with cancer are conserved in C. elegans (Kirienko et. al., 2014).  While the pathways 
and mechanisms are complex in a human setting, regulatory networks related to cancer in          
C. elegans are simplified with fewer genes involved (Hunter and Pines, 1994).  
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 For our cancer model, gld-1 knockdown in the nematode germline was used to create an 
over proliferation and tumor phenotype.  Under normal conditions, GLD-1, an RNA binding 
protein, functions as a germline specific tumor suppressor that is responsible for the transition 
from spermatogenesis to oogenesis (Nayak et. al., 2004).  The protein regulates the transition 
between mitotic division in the distal end to meiotic division at the proximal end of the gonad 
(Ciosk et. al., 2006).   GLD-1 expression is inhibited in the distal mitotic zone (Crittenden et. al., 
2002) but is observed to have higher levels of expression in the central region of the gonad 
(Jones et. al., 1996).  With loss of function mutations of gld-1, tumors develop from germ cells 
that initiate meiosis but return to mitosis prior to completion of meiotic prophase (Figure 6A and 
6B) (Francis et al., 1995).  In addition to mass mitotic division, one study has identified nuclei in 
the germline resembling nuclei found in somatic tissues upon knockdown of gld-1 but saw 
higher incidence of these nuclei in gld-1 and mex-3 knockdown (Ciosk et. al., 2006).  Further 
analysis has determined the non-germline cells were differentiated somatic cells such as muscle 
cells, neurons, and intestinal cells (Ciosk et. al., 2006).  Using gld-1 knockdown as a cancer 
model in the germline will allow observation of the effects of overexpression of ectopic PNPase 
during tumor development in a whole animal model setting.       
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Figure 7: Effects of gld-1 mutants.  Mutation in gld-1 produces a tumor-like phenotype with 
mass proliferation of mitotically dividing cells present in the proximal region of the gonad where 
meiotic division normally takes place. (Kirienko et. al., 2014)  
 
 
 
XIII. Preliminary Studies of PNPase Knockdown in C. elegans 
 Previous work has studied the phenotypic effect of PNPase knockdown in C. elegans. 
Knockdown was achieved through feeding RNAi using an RNAi clone that produced dsRNA 
corresponding to pnpt-1.  The clone consisted of a 558 base pair region 5` of exon 1 to exon 3 of 
wPNPase.  The study determined that decrease in PNPase expression caused an increase in 
lifespan due to increased ROS production. Additionally, decreased PNPase expression 
contributed to an altered fission/fusion ratio of the mitochondria but with no presentation of 
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disordered cristae.  The lack of disordered cristae could be contributed to actions of other 
pathways and recovery mechanisms (Lambert 2015).  
 
XIV. Project Outline 
The main goal of this project is to generate animal models for pnpt-1 (mutant and 
overexpression) in C. elegans to analyze their effect on mitochondrial homeostasis and induction 
of cellular senescence in a cancer model.  To carry out this plan, mutant and overexpression 
models were produced and tested for downstream phenotypes including testing the effects of 
pnpt-1 overexpression in a gld-1 nematode cancer model to determine if it ameliorates aberrant 
proliferating cells.  Strains that contain mutations in wpnpt-1 will be obtained from the CGC and 
backcrossed to generate a background removed of unlinked mutations.  Production of transgenic 
lines for an overexpression model of PNPase will first require synthesis of the ectopic construct.  
Fusion PCR will be used to create the construct under a heat-inducible promoter and it will be 
introduced into C. elegans by microinjection.  Protocols to induce expression will be optimized 
to activate exogenous PNPase expression.  Knockdown of PNPase will be achieved by RNAi 
mechanisms, following a similar protocol adopted by previous work (Lambert 2015).  Once all 
three models have be created and optimized, polycistronic transcripts and total mitochondrial 
transcripts will be quantified, and ROS levels will be measured.  A tumorous phenotype will be 
achieved using the gld-1 cancer model to produce a proliferating tumor phenotype.  
Immunofluorescence will be used to analyze germline cells in the nematode gonad and will 
determine the senescent-inducing and differentiating role of PNPase overexpression.  
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Chapter 2: Materials and Methods 
 
OP50 Liquid Cultures/Seeding NGM plates 
Nematodes were fed OP50 bacterial cultures for regular maintenance.  Bacteria from 
glycerol stocks of OP50 was streaked for isolation on LB plates.  Individual bacterial colonies 
were picked with a P200 pipette tip and placed in 3 mLs of LB liquid media.  Liquid cultures 
were incubated overnight at 37°C and 225 rpm.  Approximately 150 uL of OP50 liquid culture 
was used to seed each medium (60mm x 15 mm) NGM (nematode growth media) plate.  The 150 
uL solution was distributed among 5 individual dots on the plate surface.  Seeded plates were 
incubated overnight at 37°C and then placed in 4°C for long term storage. 
 
C. elegans Maintenance 
 C. elegans were grown on NGM and fed OP50 bacteria and maintained at 20°C.  Plates 
were individually parafilmed to prevent contamination.  All worm strains were regularly 
maintained by either chunk transferring once a week or transferring 5-10 adult hermaphrodites 
every 4 days. 
 
C. elegans Strains 
 For RNAi experiments, mutant strain CF3152 [rrf-3 (pk1426)] was obtained from Dr. 
Malene Hanson.  Mutant studies consisted of strains containing point mutations in pnpt-1:G58E 
(VC40327), G74R (VC20261), and G74E (VC20284).  VC2010, a N2 wildtype derivative, was 
used as a control for mutant studies.  These strain were obtained from the CGC and were 
generated as part of the million mutation project (Thompson et. al., 2013). 
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Frozen Stocks of Worms 
Plates of recently starved L1/L2 hermaphrodites were washed with 0.6 mLs S Buffer 
(64.5 mM K2HPO4, 43.55 mM KH2PO4, 0.1 M NaCl) and transferred to cryotubes.  Equal 
volumes of S Buffer + 30% glycerin (sterile) were added to a crytotube and vortexed to mix 
contents well.  Samples were stored in -80°C freezer. 
To reconstitute a worm line, cryotubes were thawed at room temperature and gently 
vortexed to mix contents.  Half a milliliter of solution was pipetted onto OP50 seeded NGM 
plate.  Plates were parafilmed and stored at 20°C for worms to develop. 
 
RNAi Bacterial Strains 
RNAi was induced through feeding the worms bacteria expressing dsRNA. Liquid 
bacterial cultures were initially grown overnight in LB with ampicillin (100 ng/uL) at 225 rpm at 
37°C.  Overnight cultures were diluted 1:100 in fresh LB with ampicillin (100 ng/uL).  Cultures 
were then incubated in a shaker at 225 rpm and 37°C for 3 hours.  IPTG was added (0.4 mM) 
with additional ampicillin (100 ng/uL).  Samples were returned to the 37°C shaker for 2 hours.  
Ampicillin (100 ng/uL) and IPTG (0.4 mM) were added one last time.  Plates were seeded with 
200 uL of culture per 6 cm NGM + carbenicillin (0.1 mg/mL) plate (Lambert 2015).   
Bacterial strains for RNAi were Exon 3 for knockdown of wpnpt-1 (Lambert 2015), 
L4440 for empty vector control, T74 B4-7 for dpy10, a positive control that produced the 
“dumpy” phenotype (Dr. Jill Bettinger), and 1-F308 for gld-1 (Dr. Malene Hansen) knockdown 
to produce the overgrowth phenotype in the cancer model studies.  Strain Exon 3 was 
synthesized in our lab by Laura Lambert. 
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RNAi induced strains were plated with seven L4 hermaphroditic CF3152 worms per 
plate.  L4 hermaphrodites were allowed to lay eggs overnight and removed to produced age 
matched progeny after 4 days of development.  For RNA extraction, L4 CF3152 hermaphrodites 
were not removed after overnight egg laying but were allowed to continuously lay eggs.   
 
Extracting DNA from C. elegans 
Ten to twenty adult worms were picked and dropped into 20 uL of worm lysis buffer 
(WLB) (10mM Tris (pH 8.0), 50 mM KCl, 2.5 mM MgCl2, 0.45% Tween 20, 0.45% NP-40, and 
0.05% Gelatin) with freshly added Proteinase K at a final concentration of 60 ng/uL.  The worm 
and buffer mixture was frozen at -80°C for at least 30 min.  Samples were then incubated in a 
65°C water bath for 60 minutes.  Samples were then incubated at 95°C for 15 min to inactivate 
the Proteinase K.  DNA was stored at -20°C.  For single worm PCR (SW-PCR), only one adult 
worm was picked and dropped into 20 uL of WLB with Proteinase K.  All subsequent steps 
remained the same. 
 
Extracting RNA from C. elegans 
 For mutant and transgenic lines, ten L4 hermaphrodites were transferred to fresh OP50 
seeded NGM plates.  Five 60 mm x 15 mm plates were used for each line.  For RNAi samples, 
seven L4 CF3152 hermaphrodites were transferred to RNAi carbenicillin plates.  Seven 60mm x 
15mm plates were used for each RNAi induced sample.  Progeny were allowed to develop for 
four days at 20°C prior to extracting RNA.  Worms were washed off with 1 mL of M9 twice and 
transferred to a 15 mL conical tube. Worms were pelleted at 1000 rpm for 5 min and the 
supernatant was discarded.  Worms were washed 3 more times with 5 mLs of M9.  After the 
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supernatant was removed after the final wash, 200 uL Trizol reagent (Ambion 15596026) was 
added.  Worms in Trizol were frozen at -80°C for at least 30 minutes.  Worms were then freeze-
cracked:  alternating 20 seconds in liquid nitrogen followed by 1 minute thaw in 37°C water bath 
and repeated 10 times.  The trizol/worm mixture was transferred to 1.5 mL tube and 200 uL of 
chloroform was added.  The sample was spun at 13,000 rpm at 4°C for 15 min.  The aqueous 
fraction was transferred to a new 1.5 mL tube.  An equal volume of 70% isopropanol was added 
to the aqueous fraction.  The Qiagen RNeasy Mini Kit was used for subsequent steps of RNA 
isolation following manufacturer’s instructions.  RNA samples were stored at -80°C. 
RNA samples were DNase treated using the RQ1 RNase-Free DNase Kit (Promega) to 
remove DNA contamination.  One Unit per ug RNA of RQ1 RNase-Free DNase, and RQ1 
RNase-Free DNase 10X buffer to bring the final concentration of buffer to 1X was added to the 
RNA.  The sample was incubated at 37°C for 30 minutes.  RQ1 DNase Stop Solution was added 
(same volume as 10X buffer) and samples were incubated at 65°C for 10 minutes to inactivate 
the DNase.  DNase treated RNA samples were stored in -80°C.   
 
Generating cDNA 
The following reagents were added in a 0.65 mL tube: 0.5 ug RNA, 100 ng oligo dT 
primer, 100 ng random primer, and DEPC H20 to 12 uL.  Samples were incubated at 70°C for 10 
minutes.  A mix of 1X MMLV RT buffer, 10 mM DTT, 1 mM dNTPs, 10 units RNasin 
(Promega), and 100 units of MMLV RT (Promega) was added.  Samples were incubated at 37oC 
for 1 hour followed by incubation at 95°C for 5 minutes.  cDNA was used for downstream 
applications or stored at -20°C.  
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PCR 
PCR was performed to obtain annealing conditions for qPCR, optimizing  cloning 
primers, to genotype worms for backcrosses, to create the transgenic pnpt-1 clone by traditional 
cloning methods and Gibson assembly, and to produce fragments for sequencing analysis.  Phire 
Hot Start II DNA Polymerase Kit (Thermo Fisher Scientific F122S) and its corresponding 5X 
buffer was used for all PCR reactions.  The list of primers used in PCR reactions are listed below 
along with their annealing conditions (Table 18 and 19).  PCR reaction components are found in 
Table 1 and cycling parameters were:  
 
1.5’ 94°C – [30” 94°C – 30” annealing temperature – 30” 72°C] x30 – 7’ 72°C. 
 
Reagents Final Concentration Manufacturer 
DNA X uL N/A 
5X Phire II Buffer 1X Thermo Fisher Scientific - 
F122S 
Phire Hot Start II DNA 
Polymerase 
0.05 – 0.08 uL Thermo Fisher Scientific - 
F122S 
Primers 0.5 uM IDT 
dNTPs 2mM Bioline 
Water (Hyclone Water) Bring to final reaction 
volume 
GE 
Table 1:  General PCR Protocol Outline:  List of reagents and their final concentrations for a 
PCR protocol * For backcross genotyping PCR protocol, see Table 4 ** For Fusion PCR 
experiments, see Tables 8, 10, 12, and 14.   
 
qPCR 
qPCRs were all performed at 60o C annealing temperatures under standard reaction 
conditions (Table 2).  iTaq Universal SYBR Green Supermix (Bio-Rad) was used with primers 
at a final concentration of 0.94 uM and diluted cDNA in a 15 uL single reaction.  Reactions were 
run in triplicate in a 96 well plate.  Control cDNA was used to determine ideal cDNA dilutions 
for each experiment (Table 3).  Fold changes were determined from cT, dCT, and ddCT values 
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when comparing cT values between control and sample of interest. dCT values were determine 
by: dCT = cT'() − cT+,-./ with GOI = gene of interest.  ddCT values were determined by : 
ddCT = 	dCT −	dCT,1/-213.  Fold change was determined by: Fold	Change = 2=>>?-. 
Controls for heat shocked transgenic line strains were non-heat shocked transgenic lines.  
Control for mutant lines was VC2010.  Control for Exon 3 RNAi knockdown was L4440 RNAi 
knockdown. 
 
Reagents Concentration (Volume Used) 
cDNA See dilutions Table 3 (1 uL) 
Forward/Reverse Primers (6.25 uM stock)  0.933 uM (2.24 uL) 
iTaq Universal SYBR Green Supermix (2X) 1X (7.5 uL) 
ddH20 (4.26 uL) 
Table 2:  Standard qPCR Reaction (15 uL) and reagent components 
 
 The qPCR protocol carried out is listed as follows: 
10’ 95°C – [1’ 95°C – 1’ 60°C] x40 – 15” 95°C – 1’ 60°C – 15” 95°C. 
 
qPCR Experiments (primers) cDNA Dilutions 
Determining cDNA dilution 1:8 | 1:16 | 1:32 | 1:64 
Measuring exogenous PNPase expression via 
FLAG Tag (qPCR PNPT1 FWD FLAGTAG / 
qPCR PNPT1 REV FLAGTAG) 
1:16 
Measuring endogenous PNPase expression 
(wPNPase ex 9 F / wPNPase ex 10 R) 
1:16 
Measuring actin expression (w act-2 F / w 
act-2 R) 
1:16 
Measuring polycistronic transcript 
accumulation (ctb-1 F / COIII R) 
1:4 
Measuring total mitochondrial transcripts 
(COIII Set 7 F/R) 
1:16 
Table 3: qPCR Experiments and cDNA Dilutions 
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Analysis of C. elegans pnpt-1 Point Mutations 
SIFT (Sorting Intolerant from Tolerant) and Polyphen-2 (Polymorphism Phenotyping v2) 
were used to determine the predicted deleteriousness or benign-ness of missense mutations 
located on pnpt-1.  SIFT predicts if amino acid substitutions affect protein function.  Both WT 
and mutant sequences were inputted into the software to determine the predicted degree of 
deleteriousness of the missense mutation.  Polyphen-2 determines the possible impact the amino 
acid substitution has on protein structure and function.  Both WT protein sequence and amino 
acid change were inputted into the algorithm. 
 
SIFT: https://sift.bii.a-star.edu.sg/ 
Polyphen-2: http://genetics.bwh.harvard.edu/pph2/ 
 
Determination of Mitochondrial Targeting Peptide (mTP) 
Peptide sequence was analyzed using TargetP V1.0 software to determine if worm 
PNPase contains an N-terminal mitochondrial targeting sequence or peptide motif.  Peptide 
sequence was inputted into the software and a predicted score determined if a mitochondrial 
targeting sequence was present or not. 
 
TargetP V1.0: http://www.cbs.dtu.dk/services/TargetP-1.0/ 
 
Male C. elegans generation 
 Ten L4 hermaphrodites were transferred on OP50 seeded 60 mm x 15 mm NGM plate.  
Worms were heat shocked in 30°C incubator for four hours without parafilm.  After heat shock 
  
   
46 
treatment, the plates were parafilmed and stored at 20°C.  F1 male progeny were isolated after 3-
4 days post heat shock.   
To maintain male nematode stocks, males and L4 hermaphrodites were grouped onto a 30 
mm x 15 mm plate in a 1:1 ratio and allowed to mate overnight at 20°C.  After 24 hours of 
mating, hermaphrodites were isolated and singled onto separate OP50 seeded 30 mm x 15 mm 
NGM plates.  Progeny were allowed to grow and develop for four days.  Male progeny were 
isolated and used to maintain male stocks or used for backcrossing.    
 
Backcrossing  
 Mutant hermaphrodites (VC20261, VC40327, VC20284) were backcrossed eight times to 
wildtype VC2010 N2 variant strain to produce a predicted 99.61% wildtype background.  Each 
backcross event was grouped into 2X backcrossing cycles (Figure 8). 
 Male VC2010 worms and mutant L4 hermaphrodites were transferred onto a 30 mm x 15 
mm seeded plate in a 2:1 ratio of males:hermaphrodites for mating.  Worms were allowed to 
mate overnight at 20°C.  Following overnight mating, mated mutant hermaphrodites were singled 
onto 30mm x 15mm OP50 seeded plates and allowed to lay progeny for 3 days at 20°C.  
Heterozygous male F1 progeny were isolated and mated with VC2010 L4 hermaphrodites in a 
2:1 ratio of males:hermaphrodites on a 30mm x 15mm OP50 seeded plate.  Worms were allowed 
to mate overnight at 20°C.  After mating, VC2010 hermaphrodites were singled onto 30mm x 15 
mm OP50 seeded plates and allowed to lay progeny for 3 days at 20°C.  Adult hermaphrodites of 
F1 progeny were singled onto 30 mm x 15 mm OP50 seeded NGM plates and allowed to lay 
eggs overnight.  Then, the adult hermaphrodites were genotyped using DNA extracted using the 
single worm PCR protocol.  
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Progeny of heterozygous hermaphrodites were allowed to develop for 3 days to 
adulthood.  Adult F2 progeny of F1 heterozygous hermaphrodites were singled on 30 mm x 15 
mm OP50 seeded NGM plates and allowed to lay eggs overnight.  Adult F2 hermaphrodites were 
genotyped using the single worm PCR protocol.  Extracted DNA was used for genotyping 
through PCR and digest protocols to determine the genotype of the adult hermaphrodite.  
Progeny of homozygous mutant F2 adult hermaphrodites were maintained, concluding the 2X 
Backcross cycle.  Four 2X backcross cycles were carried out for each mutant strain to produce 
the predicted 99.61% wildtype background.  Genotyping consisting of a PCR and Digest 
protocol for each mutant strain are listed below in Table 4.   
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Figure 8: 2X  Backcrossing Mechanism for Mutant Strains  
 
 
2X Backcross for Mutant Strains 
 
D1  
 
 
 
D2 
 
D5 
 
 
 
 
 
 
 
 
D6 
 
 
D10 
 
 
 
 
 
 
D11 
 
 
D15 
 
 
 
 
 
 
 
D16  
 
 
 
D17 
Mutant Hermaphrodite L4 VC2010 Adult Male 
mut / mut +  /  + 
Singled mated mutant hermaphrodite adult  
Cross 1 
F1 Progeny (50% hermaphrodites: 50% males) 
mut  /  + 
F1 Male VC2010 L4 Hermaphrodite 
mut  /  + +  /  + 
Singled mated VC2010 hermaphrodite adults 
F1 Progeny of Cross II (50% hermaphrodites: 50% males) 
Cross 2 
mut  /  + +  /  + (1:1 Ratio) 
Singled F1 Hermaphrodite adults (allowed to self-fertilize and lay embryos O.N.) 
Genotyped F1 hermaphrodite adults that were allowed to lay eggs via SWPCR 
F2 progeny from heterozygous F1 hermaphrodite adults 
mut  /  + +  /  + mut / mut (1:2:1 Ratio) 
Singled 5-10 F2 hermaphrodite adults from the heterozygous mutant 
hermaphrodite adults from SWPCR of D11 (allowed to self-fertilize and lay 
embryos overnight before genotyping) 
SWPCR of singled F2 hermaphrodite adults from D15 for genotyping.  Singled 8-10 
F2 hermaphrodite adults from mutant hermaphrodite adults from SWPCR of D11 
(allowed to self-fertilize and lay embryos before genotyping)  
SWPCR of singled F2 hermaphrodite adults from d16.  Picked worms from 
homozygous mutant F2 hermaphrodite adult plates to maintain 2x backcrossed 
mutant strain 
Tirumala 2012 
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Sample Primers PCR Product Size Digest of Mutation 
Allele 
VC40327 (G58E) PNPT1_Genomic_F / 
PNPT1_Genomic_R 
399 bp 218 bp / 181 bp 
(BstbI: NEB) 
VC20261 (G74R) VC20286/61_StyI_F 
/ Reverse 3 
152 bp 115 bp / 27 bp 
(StyI_HF: NEB) 
VC20284 (G74E) VC20286/61_StyI_F 
/ Reverse 3 
152 bp 115 bp / 27 bp 
(Sty1_HF: NEB) 
Table 4: PCR and Digest Protocol for Mutation Genotyping 
 
PCR Purification and Concentration 
 PCR products were purified and concentrated prior to sequence submissions, TA 
Cloning, Gibson Assembly, and Fusion PCR.  DNA Clean and Concentrator-5 (D4003), by 
Zymo Technologies was used to carry out this protocol.  PCR products were mixed with DNA 
Binding Buffer in a 1:5 ratio.  The mixture was transferred to the Zymo-Spin Column and spun 
down for 30 seconds at 13,300 rpm.  Flow through was discarded.  To the spin column, 200 uL 
of DNA Wash Buffer was added and was spun down for 30 seconds at 13,300 rpm.  The spin 
column was transferred to a 1.7 mL tube and 6-10 uL of DNA Elution Buffer was added to the 
column matrix.  Column matrix was allowed to incubate at room temperature for one min.  The 
spin column was then spun down at 13,300 rpm for 30 seconds.  DNA sample was stored at -
20°C for down stream applications.  
 
Sequencing 
DNA samples were Sanger sequenced using Eurofins Genomics sequencing services.  
Samples were submitted per company guidelines. 
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Gel Electrophoresis 
Depending on DNA size or application, gel electrophoresis was carried out on either 1% 
Agarose (Seakem LE) in TAE buffer or 6% acrylamide with 0.5X TBE buffer.  One percent 
agarose gels were used for gel extractions and PCR and digested products greater than 200 bp 
used.  Genotyping of SW-PCR and allele specific PCR, or PCR and digested products less than 
200 bp used 6% acrylamide gels. 
 
Gel Extraction 
Desired bands of digest products or PCR products were cut out after performing gel 
electrophoresis in agarose gels.  Excised sections were placed in Freeze `N Squeeze DNA Gel 
Extraction spin columns (Bio-Rad) and placed at -20°C for 5 minutes.  DNA was eluted at 
13,000 x g for 3 minutes at room temperature.  Purified DNA samples were stored at -20°C. 
 
TA Cloning 
Sections of the wPNPT1 cDNA were PCR amplified and ligated into pBluescript SK+ 
that had been prepared by cutting with EcoRV and t-tailed.  Prior to ligation, PCR samples were 
purified and concentrated.  The amount of PCR product used for ligation followed the formula: 
X ng PCR product =
(A	BC	DEF	CGHIJKL)(NO	/P	QRKLHG)
(STUR	TV	BC	HW	XRKLHG)
.  The ligation reaction used 3x the amount of 
PCR product for a 3:1 molar ratio between insert to vector respectively.  The reaction consisted 
of PCR product, 50 ng of vector DNA, 400 U of T4 DNA Ligase (NEB M0202S), 1x ligation 
buffer, and ddH20 to bring the final volume to 10 uL.  Ligations were incubated at 
14°C	overnight.   
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Transformations were performed using 1 uL of the ligation mix added to 50 uL of thawed 
supercompetent cells (DH5alpha, DH10b, Able C, Able K, or BL21-DE3) and incubated on ice 
for 30 minutes.  The transformation was heat shocked in a 42°C water bath for 30 seconds 
followed with a 2 minute incubation on ice.  LB media (950 uL) was added to the mixture and 
incubated in a 37°C shaker for 1 hour.  Cells were plated onto LB ampicillin plates (0.1 mg/mL 
ampicillin) prepped with 20 uL of X-Gal and 0.09 M IPTG.  Plates were incubated overnight at 
37°C.   
 
Gibson Assembly 
Individual cloned fragments of pnpt-1 were assembled using NEBuilder HiFi DNA 
Assembly (NEB E2621G).  Transformed bacteria containing cloned gene fragments were 
miniprepped and digested to isolate pnpt-1 fragments.  Digest products were extracted after gel 
electrophoresis through Freeze `N Sqeeze DNA Gel Extraction Spin Columns (Bio-Rad).  
Protocol for ligating 2-3 fragments in a single reaction (2-3 Fragment assembly) was followed 
per manufacturer guidelines.  
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PCR Fusion  
 
 
Figure 9: Outline of PCR Fusion plan to anneal individual segments of pnpt-1, hsp-16.41, and 
unc-54 3` UTR.  Colored squares represent overlap regions. 
 
Individual segments of pnpt-1, hsp-16.41 promoter, and unc-54 3`-UTR with overlapping 
segments were assembled using a series of PCR reactions.  The hsp-16.41 promoter, and unc-54 
3`-UTR fragments were obtained from PCR reactions using vector pPD48.93 as a template 
(Table 5).  Fragments were assembled either 2 or 3 at a time using Q5 Hot Start High Fidelity 
DNA Polymerase (NEB M0493S).  Reaction mix contained equimolar ratio of individual 
fragments, Q5 Hot Start High-Fidelity DNA Polymerase, 1X buffer, and ddH20 to volume.  
Forward and reverse primers were added unless otherwise stated.  Thermocycler protocols are 
listed below.  Outline of the multistep PCR Fusion Protocol is displayed above in Figure 9.  
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Fusion PCR – Step 1: Amplification of the Individual Fragments 
 
The primers, templates, annealing temperatures, fragment sizes to produce the five 
fragments for the PCR fusion are described in Table 5. PCR reactions are show in Table 6.  PCR 
cycles used were 30” 98°C – [10” 98°C – 30” annealing temperature – 40” 72°C] x30 – 2’ 72°C. 
 
Fragment 
Produced 
Primers Template Annealing 
Temperature 
Product  
Size 
hsp-16.41 PNPT1_Forward_A / 
PNPT1_Reverse_B 
vector pPD 
49.83  
54.7°C 541 bp 
wPNPT1 
Fragment 1+2 
PNPT1_Forward_C / 
PNPT1_Reverse_D 
wPNPT1 
Fragment 1+2 
in vector 
pBSSK  
56.8°C 1357 bp 
wPNPT1 
Fragment 3 pt 1 
wPNPT1Frag3F /  
wPNPT1_Frag3_pt1_R 
wPNPT1 
Fragment 3 part 
1 in vector 
pBSSK 
58.4°C 558 bp 
wPNPT1 
Fragment 3 pt 2 
wPNPT1_Frag3_pt2_F 
/ PNPT1_Reverse_H 
wPNPT1 
Fragment 3 part 
2 in vector 
pBSSK 
58.4°C 511 bp 
unc-54 3` UTR PNPT1_Forward_I /  
PNPT1_Reverse_J 
vector pPD 
49.83 
54.7°C 737 bp 
Table 5: Primer, Template, Annealing Temperature, and Product Size of Step 1 
 
 
PCR Protocol 
Reagents 
(stock concentration) 
Concentration/Amount 
Used 
Manufacturer 
DNA (2pg/uL stock) 5 uL  
5X Q5 Reaction Buffer 5 uL NEB M0495S 
Q5 HiFi 0.25 uL NEB M0493S 
dNTPs (2.5 mM stock) 2 uL(0.2 mM) Bioline 
Primers (6.25 uM stock) 2 uL each  (1 uM) IDT 
Water (Hyclone) 8.75 uL GE 
Total Volume  25 ul  
Table 6:  Step 1 PCR Protocol for PCR Fusion 
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Fusion PCR – Step 2A Combining Fragments 
 To combine the overlapping fragments, the fragments generated above are denatured and 
anneal with one another and therefore become both the template and primer for the amplification 
reaction. In this step the promoter and pnpt-1 fragment 1 + 2 are combined (fragment 5’) and the 
three most 3’ fragments are annealed (fragment 3’) (Table 7).  PCR Reaction are shown in Table 
8.  The cycling parameters used for these reactions were 30”  98°C – [10” 98°C – 30” 58°C – 1’ 
72°C] x15 – 2’ 72°C. 
 
Fragment 
Produced 
Templates Annealing 
Temperature 
Product Size Equimolar 
Concentrations 
of Fragments 
used 
Fragment 5’ hsp-16.41 / 
wPNPT1 
Fragment 1+2 
58°C 1898 bp 0.22 pmols 
Fragment 3’ wPNPT1 
Fragment 3 pt1 / 
wPNPT1 
Fragment 3 pt2 / 
unc-54 3` UTR 
58°C 1809 bp 0.41 pmols 
Table 7: Template, Annealing Temperature, and Product Size of Step 2A 
 
 
 
Reagents 
(Stock concentration) 
Concentration/Amount 
Used 
Manufacturer 
DNA  X uL  (see table 7)  
5X Q5 Reaction Buffer 20 uL NEB M0495S 
Q5 HiFi 1 uL NEB M0493S 
dNTPs (2.5 mM stock) 8 uL (0.2 mM) Bioline 
Water (Hyclone) X uL to bring  to final volume GE 
Total reaction volume 100 ul  
Table 8: Step 2A PCR Protocol for PCR Fusion 
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Fusion PCR – Step 2B Generating Additional Copies of Fragments 
 Step 2B consisted of amplification of fused fragments 5’ and 3’ from Step 2A for use for 
the next fusion step (Tables 9 and 10).   The fragments were run on a 1% agarose gel and the 
fragments were excised and extracted from the gel but not purified cycling parameters were: 30” 
98°C – [10” 98°C – 30” annealing temperature – 1’ 72°C] x35 – 2’ 72°C. 
 
Fragment 
Produced 
Primers Template Annealing 
Temperature 
Product 
Size 
Fragment 5’ PNPT1_Forward_A 
/ 
PNPT1_Reverse_D 
PCR fusion 
product 
Fragment 5’ 
59.1 / 60.1°C 1898 bp 
Fragment 3’ wPNPT1Frag3F / 
PNPT1_Reverse_J 
PCR fusion 
product 
Fragment 3’ 
58 / 59.1°C 1809 bp 
Table 9: Primer, Template, Annealing Temperature, and Product Size of Step 2B 
 
 
PCR Protocol 
Reagents 
(Stock concentration) 
Concentration/Amount 
Used 
Manufacturer 
Gel extracted DNA  2 uL  
5X Q5 Reaction Buffer 10 uL NEB M0495S 
Q5 HiFi 0.5 uL  NEB M0493S 
dNTPs (2.5 mM stock) 4 uL (0.2 mM) Bioline 
Primers (6.25 uM stock) 4 uL each (1 uM) IDT 
Water (Hyclone) 25.5 uL GE 
Total reaction volume 50 ul  
Table 10: Step 2B PCR Protocol for PCR Fusion 
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Fusion PCR – Step 3A Combining of Fragments 5’ and 3’ 
 Step 3A consisted of fusing the two large fragments together at the overlapping region 
again with the annealed fragments serving as primer and template. (Tables 11 and 12).  This 
fragment was called FSN PCR. The PCR cycling parameters were: 30” 98°C – [10” 98°C – 30” 
58°C – 2’ 72°C] x15 – 2’ 72°C. 
 
Fragment 
Produced 
Templates Annealing 
Temperature 
Product Size Equimolar 
Concentrations 
of Fragments 
used 
FSN PCR Fragment 5’/ 
Fragment 3’ 
58°C 3707 bp 0.23 pmols 
Table 11: Template, Annealing Temperature, and Product Size of Step 3A 
 
 
PCR Protocol 
Reagents 
(Stock concentration) 
Concentration/Amount 
Used 
Manufacturer 
DNA  X uL (see table 11)  
5X Q5 Reaction Buffer 20 uL NEB M0495S 
Q5 HiFi 1 uL NEB M0493S 
dNTPs (2.5 mM stock) 8 uL (0.2 mM) Bioline 
Water (Hyclone) X uL to bring to final volume GE 
Totalreaction volume 100 ul  
Table 12: Step 3A PCR Protocol for PCR Fusion 
 
 
Fusion PCR – Step 3B Generating Additional Copies of the Fused FSN PCR Product  
 Step 3B consisted of amplification of the FSN PCR product created from Step 3A with 
nested primers to generate material for worm injections (Tables 13 and 14). PCR protocol ran as 
follows: 30” 98°C – [10” 98°C – 30” 58°C – 2’ 72°C] x35 – 2’ 72°C. 
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Fragment 
Produced 
Primers Template Annealing 
Temperature 
Product 
Size 
FSN PCR PNPT1_Nested_Forward 
/ PNPT1_Reverse_J 
FSN PCR 58°C 3707 bp 
Table 13: Primer, Template, Annealing Temperature, and Product Size of Step 3B 
 
 
PCR Protocol 
Reagents 
(Stock concentration) 
Concentration/Amount 
Used 
Manufacturer 
Gel Extracted DNA  3 uL  
5X Q5 Reaction Buffer 10 uL NEB M0495S 
Q5 HiFi 0.5 uL NEB M0493S 
dNTPs (2.5 mM stock) 4 uL(0.2 mM) Bioline 
Primers (6.25 uM stock) 4 uL each (1 uM) IDT 
Water (Hyclone) 24.5 uL GE 
Total Reaction Volume 50 ul  
Table 14: Step 3B PCR Protocol for PCR Fusion 
 
 
pnpt-1 Overexpression Transgenic Line Generation 
 
Microinjections were carried out in young adult hermaphroditic worms into VC2010 or 
CF3152 strains by Dr. Laura Mathies.  Equal amounts (100 ng) of pPD49.83 heat shock vector 
or FSN PCR (PCR Fusion construct) with pTG96 suf-5::GFP reporter vector were added in a 40 
uL reaction mix.  Reaction mixes were injected into the gonad arm of young adult 
hermaphrodites.  suf-5::GFP is expressed in the nucleus of somatic cells (Gonzalez-Serricchio et. 
al., 2006) and serves as a co-injection marker. 
 
Transgenic Line Stabilization 
Stable transgenic pnpt-1 overexpression VC2010 and CF3152 lines were selected over 
three generations.  For each generation, five to ten GFP expressing hermaphrodites were singled, 
allowed to mature, and produce eggs and the progeny screened for GFP-expression.  Regular 
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nematode maintenance followed after stabilization of the line and propagated with GFP-
expressing animals.   
 
Overexpression of pnpt-1 
Method 1 
Ten adult transgenic hermaphrodites expressing GFP were transferred onto medium 
OP50 seeded plates.  Plates were parafilmed and placed in 20°C for 4 days until F1 progeny 
developed into adults.  GFP-expressing nematodes were heat shocked for 2 intervals of 2 hours 
at 30°C  without parafilm with a 30 min break at 20°C between the two heat shock incubations.   
 
Method 2 (Cancer Models) 
Five adult transgenic hermaphrodites expressing GFP were transferred onto medium gld-
1 RNAi seeded plates.  Plates were parafilmed and placed in 20°C for 3 days until F1 progeny 
developed into L4’s.  Plates were heat shocked at 30°C for 2 hours at L4 stage (day 3) and adult 
stage (day 4) without parafilm.  Worm plates were parafilmed and stored at 20°C in between 
when worms were heat shocked. 
 
Western Protocol 
Protein Extractions 
Ten L4 hermaphrodites were transferred to newly seeded NGM plates.  Each strain was 
staged on 5 plates.  Progeny were allowed to develop for 4 days at 20°C prior to sample 
preparation for protein extraction.  Plates of nematodes were washed with 1mL of M9 2X and 
collected in a 15 mL tube.  Worms were pelleted at 1,000 rpm for 5 minutes, and the supernatant 
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was discarded . They were then washed with 5 mLs of fresh M9 buffer 3X.  Protease inhibitor 
cocktail (Sigma 8340) was added in a 1:100 dilution to the 300 uL worm pellet in M9 prior to 
storage in -80°C.  When ready to use worm pellets were thawed and transferred to a 1.7 mL tube 
and 200 uL of 1X RIPA Buffer (Cell Signaling Technologies #9806) was added to the pellet.  
Samples were homogenized with a pellet pestle for 2 minutes.  They were then placed on ice and 
gently rocked on a platform shaker for 20 minutes at 4°C.  Samples were spun down at 13,300 
rpm for 1 minute at 4°C.  Supernatant consisting of protein lysates was transferred to a new 1.7 
mL tube and kept on ice to measure the concentration using the Lowry Assay. 
 
Lowry Protein Assay 
The DC Protein Assay (Bio-Rad) was used to measure concentrations of protein lysates.  
A standard curve was generated using 25 uL BSA standards (0.125 mg/mL, 0.25 mg/mL, 0.5 
mg/mL, 1 mg/mL, and 1.4 mg/mL).  Protein lysates were diluted with ddH20 to a 1:5 ratio 
respectively.  Final version of Reagent A was prepared by mixing a ratio of 20 uL of Reagent S 
and 1 mL of Reagent A.  Then, final version of reagent A (125 uL) mix and Reagent B (1mL) 
were added to 25 uL BSA standards and protein samples and samples were inverted 5 times to 
mix the reagents.  Samples were allowed to incubate at room temperature for 15 minutes.  BSA 
standards were read at 750 nm with Beckman Coulter DU 530 DNA/Protein Analyzer 
Spectrophotometer to produce the standard curve.  Protein lysates were read and plotted against 
the standard curve to determine concentration.  Protein lysate samples were aliquoted into 50 ug 
aliquots and stored at -80°C. 
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Western Analysis  
 4X Laemmli Sample Buffer (BioRad – 161-0747) was added to the 50 ug aliquots of 
protein lysates to bring the final concentration of Sample Buffer to 1X.  Samples were boiled at 
100°C for 10 minutes followed bypelleting in a 4°C centrifuge at 13,300 rpm for 30 seconds.  
Supernatents were loaded onto a 7.5% acrylamide resolving gel and a 3.9% acrylamide stacking 
gel with 10 uL protein standard (Bio-Rad 161-0374).  Gel electrophoresis of the protein lysates 
was carried out at 100 volts for ~2 hours in 1X Tris glycine running buffer.  After gel 
electrophoresis, the stacking gel was discarded and the resolving gel was prepped for transfer.  
The gel was soaked in 1X transfer buffer for >15 minutes and the protein lysates were transferred 
onto an Immun-Blot PVDF Membrane for Protein Blotting (Bio-Rad 162-0177).  The membrane 
was prepped prior to the transfer step by soaking in cold methanol for 15 seconds, ddH20 for 2 
minutes, then 1X transfer buffer for > 5 minutes.   
The transfer step was carried out in 1X transfer buffer with methanol for ~2 hours at 100 
volts with an ice block in the gel box.  During the 2 hour transfer, the ice block was replaced 
with a new ice block every 30-40 minutes to keep the gel box cold.  After the transfer step, the 
membrane was removed from the cassette and rinsed in TBS for 10 minutes on a platform shaker 
at room temperature.          
 
Block / Primary Ab / Secondary Ab 
After blocking for 4 hours at room temperature, membranes were rinsed in TBST prior to 
incubation in primary Ab overnight at 4°C.  After primary Ab incubation, membranes were 
washed in TBST for 3 x 10 minutes on platform shaker prior to secondary Ab application.  After 
secondary Ab incubation, membrane was rinsed 2 x 10 minutes in 5% milk/TBST, rinsed in 
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TBST, and then washed in TBST for 10 minutes on platform shaker. Parameters for protein 
detection of specific antibodies are found in Table 15. 
 
Antibody (Experiment) Block Primary Ab Secondary Ab 
FLAG Tag 
(Determining exogenous 
PNPase protein 
synthesis) 
5% milk/TBST  
 
 
Monoclonal Anti-FLAG 
M2 Produced in Mouse 
(Sigma F1804)  
 
1:1000 dilution in 3% 
milk/TBS 
 
Incubate covered at 4°C 
overnight 
ECL Anti Mouse IgG 
Horseradish Peroxidase-
linked Whole Antibody 
from Sheep (GE 
Healthcare NA931V) 
 
1:10,000 dilution in 5% 
milk/TBST 
 
Incubate covered for 
~45 min at room 
temperature on platform 
shaker 
alpha-Tubulin (loading 
control) 
5% milk/TBST  
 
 
Anti-alpha-Tubulin 
(Mouse Monoclonal) 
(Sigma T6199)  
 
1:5000 dilution in 5% 
milk/TBST 
 
Incubate covered at 4°C 
overnight 
ECL Anti Mouse IgG 
Horseradish Peroxidase-
linked Whole Antibody 
from Sheep (GE 
Healthcare NA931V) 
 
1:10,000 dilution in 5% 
milk/TBST 
 
Incubate covered for 
~45 min at room 
temperature on platform 
shaker 
Table 15: Parameters and Conditions for Antibodies 
 
Detection 
 Antibodies were detected through chemiluminescence using Super Signal West Femto 
Maximum Sensitivity Substrate Kit (ThermoFisher 34096).  Stable Peroxide Solution and 
Luminol/Enhancer Solution were mixed in a 1:1 ratio.  Membranes were placed in the detection 
solution protein-side down and incubated at room temperature for 5 minutes and wrapped in 
plastic wrap.  Membraned were exposed to X-ray film in a dark room for 5-10 seconds and then 
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15-30 seconds.  Film was developed in a Kodak film developer.  Membrane was stored in TBS at 
4°C. 
 
Stripping 
 BlotFresh Western Blot Stripping Reagent Ver II (SignaGen Laboratories SL100324) 
reagent was used to strip membranes prior to reapplication of antibodies.  Membranes were 
placed in 30 mLs of stripping reagent on a platform shaker for 10 minutes at room temperature.  
Membraned were then washed in TBST for 2X 10 minutes on a platform shaker.  
 
Immunofluorescence 
Poly-L-Lysine Slide Preparation 
ColorFrost Plus Slides (Fisher Scientific) were coated with poly-L-Lysine solution 
(Sigma Aldrich P8920).  Poly-L-Lysine solution was diluted 1:1 with ddH20.  Slides were 
briefly heated at “setting 4” on a hot plate.  Ten microliters of solution was added to one heated 
slide and sandwiched to another heated slide to spread solution.  Slides were separated and 
residual Poly-L-Lysine solution were left to dry at room temperature.   
 
Edgar Buffer Dissecting Media  
Worms were dissected in 20 uL of Edgar’s Buffer.  Buffer consisted of 60 mM NaCl, 32 
mM KCl, 3 mM Na2HPO4, 2 mM MgCl2, 2 mM CaCl2, 5 mM HEPEs, 0.2% glucose pH 7.2.  
The buffer was filter sterilized and stored in 4°C.  Levamisole hydrochloride (Sigma L-9756) at 
25 mM concentration was added to Edgars Buffer in a 1:100 ratio prior to dissection.  
Levamisole served as a paralytic aide for gonad isolation and dissection.     
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Gonad Isolation 
Worms were placed in 20 uL of Edgar’s Buffer with 0.25 mM levamisole on a poly-L-
Lysine coated charged slide.  A 30 gauge needle was used to open the nematode at the pharynx.  
Gonad arms and the other internal organs were separated using an eyebrow hair attached to a 
tooth pick.  Four dots of vacuum jelly were placed around the dissection media and a 22 mm x 
50 mm coverslip (Fisherbrand 12-543-C) was placed on top and slightly depressed until touching 
the gonad arms and dissected worms.  Slide was then placed in liquid nitrogen until all 
dissections were completed.  Upon completion, slides were taken out of liquid nitrogen and 
freeze-cracked by flicking off the coverslip.  Slides were immediately placed in fixation media. 
 
Fixation 
 Samples were fixed in cold 100% methanol for 4 minutes followed by 4 minutes in cold 
acetone.  Coplin jars contained Type 3A molecular sieves at the bottom of the jar for static 
dehydration in the fixation media.  Fixation media was chilled in wet ice for >15 minutes prior to 
fixation of dissected samples after freeze cracking.  
Following fixation, slides were washed in 1X PBS for 3X for 5 minutes on a platform 
shaker.  Slides were soaked in 50 mL blocking solution in a coplin jar and incubated for ~20 
minutes on platform shaker at room temperature.  Blocking media consisted of 0.5% BSA, 
0.04% azide, and 0.01% Tween-20 in 1X PBS.  Reagent was filter sterilized with Steriflip 
Vacuum-driven Filtration System with 0.22 um membrane (Millipore Sigma – SE1M179M6) 
and stored at 4°C. 
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A hydrophobic ring was placed around the sample on the slide with vacuum grease (Dow 
Corning High Vacuum Grease) and 30 uL primary antibody solution was pipetted on top of the 
samples.   
Samples were incubated with primary antibody for 2 hours in a humid chamber.  Humid 
chamber consisted of a Tupperware container with soaked paper towels lining the bottom and 
pipette tip wafers serving as an elevated platform for the slides.  Antibody buffer solution 
consisted of 3% BSA, and 1% azide in sterile ddH20.  The reagent was filter sterilized with 
Steriflip Vacuum-driven Filtration System with 0.22 um membrane (Millipore Sigma – 
SE1M179M6) and stored at 4°C.  Following primary antibody incubation, slides were washed in 
1X PBS 3X for 10 min on a platform shaker.  Excess 1X PBS was wiped off and 30 uL of 
secondary antibody solution was pipetted on top of the sample.  Samples were incubated in the 
dark for 2 hours in a humid chamber.  Slides were then washed in 1X PBS for 3 X five minutes 
on a platform shaker and dip washed in ddH20.  Excess solution and hydrophobic grease ring 
was wiped off using a kimwipe.  Five to ten microliters of Fluoro-Gel II Mounting Medium 
(Electron Microscopy Sciences 17985-50) solution was added to an 18 mm x 18 mm coverslip 
and coverslip was placed on top of the slide covering the sample.  Samples were incubated 
overnight at 4°C in a slide folder.  Antibody information for primary and secondary antibodies 
and the double staining protocol for FLAG-Tag and K76 are listed in the tables below (Table 16 
and 17). 
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Antibody Description 
K76 (Developmental Studies Hybridoma 
Bank) 
Anti-PGL-1 for p granules detection  
Rabbit ANTI-FLAG antibody (Sigma F7425) Polyclonal Flag tag antibody produced in 
rabbit  
Donkey anti-Mouse IgG (H+L) Highly Cross-
Adsorbed Secondary Antibody, Alexa Fluor 
488 (Thermo Fisher A21202) 
Alexa Fluor 488 Donkey anti Mouse  
Donkey anti-Rabbit IgG (H+L) Highly Cross-
adsorbed Secondary Antibody, Alexa Fluor 
568 (Thermo Fisher A10042) 
Alexa Fluor 568 Donkey anti Rabbit  
Table 16: Primary and Secondary antibody list and associated description 
 
 
Protocol Primary Ab Secondary Ab 
FLAG-Tag and K76 Anti-Flag (Rabbit): 1:3000 
dilution 
 
K76: Final concentration of 5 
ug/mL 
Alexa Fluor 488 Donkey anti 
Mouse: 1:4000 
 
Alexa Fluor 568 Donkey anti 
Rabbit: 1:4000 
Table 17: Double Staining Protocol for FLAG-Tag and K76 
 
ROS Assay 
Seven L4 hermaphroditic worms were picked onto RNAi or NGM plates and allowed to 
mature and lay eggs overnight (up to 24 hours).  Adults were removed from the plates the next 
day and eggs were allowed to mature into adults over the next three days.  At least 150 adult 
hermaphrodites were picked and transferred to a new seeded RNAi or NGM plate.  For 
transgenic lines, adult GFP-expressing hermaphrodites were picked and transferred to a seeded 
NGM plate.  Fifty worms were individually picked and dropped into 0.65 mL tubes containing 
250 uL of 1X Sample Buffer from AmplexRed (Life Technologies) kit in triplicate.  Worms 
were spun down at 15,000 rpm for 2 min and 150 uL of supernatant was removed. Worms were 
washed for a total of 4X.  One hundred microliters of 1X Sample Buffer was added to the tube 
and samples were pulsed on a vortex at maximum speed.  Tubes were spun down at 1,000 rpm 
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for 2 mins and 100 uL of supernatant was removed.  Fifty uL of worms/1X Sample Buffer 
mixture were aliquoted into a 96 well plate. 
DMSO and 1 vial of Amplex Red Reagent were allowed to thaw to room temperature 
while covered from light.  Sixty uL of thawed DMSO was added to the Amplex Red Reagent 
vial to dissolve the contents.  This step was done right before preparing the working solution.   
1X Sample Buffer was prepared by diluting 4 mL of 5X Sample Buffer with 16 mLs of sterile 
deionized water.  Next, 22.7 uL of 3% HZOZ was mixed with 977 uL of 1X Sample Buffer to 
produce 20 mM HZOZ. The 20 mM HZOZ diluted stock was further diluted to 0.01 mM in 1X 
Sample Buffer to produce the positive control.  1X Sample Buffer served as the negative control.  
A vial of Horseradish Peroxidase (HRP) was mixed with 1 mL of 1X Sample Buffer.  The 
solution was divided into single use 100 uL aliquots and stored at -20C.   
After transferring worm samples and the positive and negative controls to the 96 well 
plate, a working solution were prepared with 100 uM Amplex Red Reagent and 0.2 U/mL HRP.  
Fifty microliters of working solution was added to each sample well.  The 96 well plate was 
loosely covered with parafilm and incubated at room temperature and covered from light.  
Absorbance readings were taken with a BioTek SYNERGY|HTX multimode reader at 540 nm 
and 620 nm after 30 minute incubation and 2.5 hour incubation.  Measured values were analyzed 
with Gen5 2.06 software. 
Final amounts of HZOZ was determined by subtracting the 540 nm absorbance values 
from the 620 nm absorbance values.  Triplicates were averaged and significance of differences 
were determined with a t-test. 
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Table 18 – Primer List 
Primer Name Sequence Notes/Desc 
wPNPT1_Genomic_F AGT GGA ATC GAG CTG 
AAA GC 
For sequencing mutant strains 
wPNPT1_Genomic _R TTG CTG ACG CTG ACG 
GTC T 
For sequencing mutant strains 
and reverse primer for allele 
specific PCR for VC20284 
and VC20261 
VC40327_G_F GTA AGA CCG TAG TTG 
CTT CAT TCC G 
Allele specific PCR for 
genotyping for VC40327 
(Mutant allele) 
VC40327_A_F ACT CTA GTA GAC ATA 
ACC GTA GTT GCT TCA 
TCC GA 
Allele specific PCR for 
genotyping for VC40327 
(wildtype allele) 
Reverse 2 CCG ATA TTC AAC TTG 
TAG CGG 
Allele specific PCR for 
genotyping for mutant line 
VC40327 
VC20284_G_F GTA AGC AAC GGA AAT 
CCA AGC AAC G 
Allele specific PCR for 
genotyping for VC20284 
(mutant allele) 
VC20284_A_F AAG CAT CTC AAG CAT 
CAA CGG AAA TCC AAG 
CAG GA 
Allele specific PCR for 
genotyping for VC20284 
(wildtype allele) 
Reverse 3 GCT GAC GGT CTG GAA 
TTT TCA G 
Allele specific PCR for 
genotyping for mutant lines 
VC20284 and VC20261 
VC20261_G_F CAG AGC AAC GGA AAT 
CCA AGC ATG 
Allele specific PCR for 
genotyping for VC20261 
(mutant allele) 
VC20261_A_F GAA GCA TCT CAA GCA 
CAA CGG AAA TCC AAG 
CGA A  
Allele specific PCR for 
genotyping for VC20261 
(wildtype allele) 
VC20284/61_StyI_F CCG CAG GTA GTA CAA 
CGG AAA TCC AAC CAA 
Allele specific PCR for 
genotyping for VC20261 and 
VC20284  
PNPT1_Nested_Forward GCA GGT CGA CTC TAG 
AGG ATC AC 
Primer for amplifying final 
Fusion PCR construct and 
sequencing Fusion PCR 
construct 
PNPT1_Forward_A ATG ACC ATG ATT ACG 
CCA AGC 
Fusion PCR: Forward primer 
for hsp-16.41 promoter 
PNPT1_Reverse_B GGC AAC CGG GAA AGT 
TTC ATA GAT ATC AAT 
ACC ATG GTA CCG TCG 
Fusion PCR: Reverse primer 
for hsp-16.41 promoter  
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PNPT1_Forward_C ATG AAA CTT TCC CGG 
TTG CC 
Fusion PCR: Forward primer 
for wPNPT1 Fragment 1+2 
PNPT1_Reverse_D AAA CCT GGC ATG CGA 
GCC GT 
Fusion PCR: Reverse primer 
for wPNPT1 Fragment 1+2 
wPNPT1Frag3F 
 
GCC GAT TTC CCA TAC 
GCC AC 
Fusion PCR: Forward primer 
for wPNPT1 Fragment 3 part 
1 | Forward primer for 
wPNPt1 Fragment 3 pt1 for 
cloning 
wPNPT1_Frag3_pt1_R CTG AGC CAA CAG TGA 
GAT GTG AGC 
Fusion PCR: Reverse primer 
for wPNPT1 Fragment 3 part 
1 | Reverse primer for 
wPNPT1 Fragment 3 pt1 for 
cloning 
wPNPT1_Frag3_pt2_F GCA AGT TGA TCG AGG 
CGG AG 
 
Fusion PCR: Forward primer 
for wPNPT1 Fragment 3 part 
2 | Forward primer for 
wPNPt1 Fragment 3 pt32for 
cloning 
PNPT1_Reverse_H GGA CTT AGA CAG AGG 
CAC GGT CAC TTG TCG 
TCA TCG TCT TTG TAG 
TCC 
Fusion PCR: Reverse primer 
for wPNPT1 Fragment 3 part 
2 
PNPT1_Forward_I CCG TGC CTC TGA CTT 
CTA AGT CC 
Fusion PCR: Forward primer 
for unc-54 3` UTR 
PNPT1_Reverse_J CGT ACG GCC GAC TAG 
TAG GAA 
Fusion PCR: Reverse primer 
for unc-54 3` UTR 
FSNPCR_Seq_Check_F TCA GGA GGA CCC TTG 
GCT AGC GTC 
Sequencing Fusion PCR 
construct in transgenic strains 
FSNPCR_Seq_Check_R GAG CAT GTA GGG ATG 
TTG AAG AGT AAT TGG 
Sequencing Fusion PCR 
construct in transgenic strains 
FSN_Seq_CheckV2_F CGG TAC CAT GGT ATT 
GAT ATC TAT GAA AC 
Did not use 
FSN_Seq_CheckV2_R CAG AGG CAC GGT CAC 
TTG TCG 
Did not use 
PNPT1_Missing_F AGT GCT CCG CGA CAC 
CAC 
Sequencing section of FSN 
PCR construct of wPNPT1 
PNPT1_Missing_R GAC TGA AGC CAT TGA 
TGA TGA GCC 
Sequencing section of FSN 
PCR construct of wPNPT1 
qPCR PNPT1 FWD 
FLAGTAG 
GCG ATG AGC ACA CTG 
GAA ATA 
qPCR for exogenous 
wPNPT1 expression 
qPCR PNPT1 REV 
FLAGTAG 
CGT CAT CGT CTT TGT 
AGT CCT TT 
qPCR for exogenous 
wPNPT1 expression 
wPNPT1 Frag3 FLAG_R TCA CTT GTC GTC ATC 
GTC TTT GTA GTC CTT 
Amplification of Fragment 3 
of wPNPT1 for cloning 
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TTT TTT CTG TGA CGT 
GGC AGG TG 
COIII FWD Set 7 ACA GTA ACT TGA GCA 
CAT CAC A 
Measuring total 
mitochondrial transcripts with 
qPCR 
COIII REV Set 7 AAA TGC TAA GAA CAA 
ACC ACC AC 
Measuring total 
mitochondrial transcripts with 
qPCR 
COIII FWD Set 3  GCC TCA GC GGA ATG 
TTA 
Measuring total 
mitochondrial transcripts with 
qPCR 
COIII REV Set 3 GTG ATC AAG TCT CTC 
CCA ACT C 
Measuring total 
mitochondrial transcripts with 
qPCR 
ctb-1 F AAG ATG ACT AGG TCA 
ATG CA 
qPCR testing for 
polycistronic transcripts 
COIII R TAT GCA TAC CTT GAA 
AGT CT 
qPCR testing for 
polycistronic transcripts 
w act-2 F ATC GTC CTC GAC TCT 
GGA GAT G 
Worm actin | loading control 
for qPCR 
w act-2 R TCA CGT CCA GCC AAG 
TCA AG 
Worm actin | loading control 
for qPCR 
wPNPase ex 9 F ATG ATG AAT GAT GTG 
CTC GA 
qPCR for total PNPase 
expression  
wPNPase ex 10 R GGA TTC AGG CTT AGG 
TGG TT 
qPCR for total PNPase 
expression 
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Table 19 – Primer Annealing Temperature 
Primer Pairs Annealing Temperature Product Size 
wPNPT1 Frag 3F / wPNPT1 Frag 3 
FLAGR 
60°\ 919 bp 
wPNPT1 Frag 3F / wPNPT1 Frag 3 
pt1 R  
60°\ 554 bp 
wPNPT1 Frag 3 pt2 F / wPNPT1 
Frag 3 FLAG R 
60°\ 443 bP 
wPNPT1_Genomic_F / 
wPNPT1_Genomic_R 
58°\ 399 bp 
VC40327_G_F / Reverse 2  55 / 60 / 63 / 65.1 / 66.6°C 110 bp 
VC40327_A_F / Reverse 2 60 / 65.1 / 66.6°C 120 bp 
VC20284_G_F / PNPT1 Genomic R 58 / 60°C 154 bp 
VC20284_G_F / Reverse 3 58 / 60 / 63 / 66.6 / 68.7°C 146 bp 
VC20284_A_F / PNPT1 Genomic R 58 / 60°C 164 bp 
VC20284_A_F / Reverse 3 58 / 60 / 63 / 65.1 / 66.6 / 
68.7 / 70.3°C 
156 bp 
VC20261_G_F / Reverse 3 55 / 63 / 65.1 / 66.6 / 68.7 / 
70.3°C 
147 bp 
VC20261_A_F / Reverse 3 55 / 58 / 60 / 63 / 65.1 / 66.6 
/ 68.7 / 70.3°C 
157 bp 
VC20284/61_StyI_F / Reverse 3 63°C 152 bp 
PNPT1_Forward_A / 
PNPT1_Reverse_B 
54.7°C 541 bp 
PNPT1_Forward_C / 
PNPT1_Reverse_D 
56.8°C 1357 bp 
wPNPT1Frag3F / 
wPNPT1_Frag3_pt1_R 
58.4°C 558 bp 
wPNPT1_Frag3_pt2_F / 
PNPT1_Reverse_H 
58.4 / 59 / 59.7 / 60 / 60.5 / 
61°C (3 temperatures used) 
511 bp 
PNPT1_Forward_I / 
PNPT1_Reverse_J 
54.7°C 737 bp 
PNPT1_Forward_A / 
PNPT1_Reverse_D 
59.1 / 60.1°C 1898 bp 
Forward E / PNPT1_Reverse_J 58 / 59.1°C 1898 bp 
PNPT1_Nested_Forward / 
PNPT1_Reverse_J 
58°C 3707 bp 
FSNPCR_Seq_Check_F / 
FSNPCR_Seq_Check_R 
60°C 3074 bp 
PNPT1_Missing_F / 
PNPT1_Missing_R 
58.2 / 59 / 60.1 / 61.1 / 
61.7°C 
427 bp 
qPCR_PNPT1_FWD_FLAGTAG / 
qPCR_PNPT1_REV_FLAGTAG 
60°C 102 bp 
wPNPase ex9 F / wPNPase ex10 R ]^°C 161 bp 
COIII Set 3 FWD / COIII Set 3 REV 60°C 283 bp 
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COIII set 7 FWD / COIII Set 7 REV 60°C 219 bp 
w act-2 F / w act-2 R 60°C 101 bp 
ctb-1 F/COIII R 60°C 231 bp 
** Bold temperatures used and finalized after optimizing conditions 
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Chapter 3: Results 
 
Mutant Studies of PNPase in C. elegans 
 The goal of the mutant studies was to identify strains that contained mutations located in 
pnpt-1 and to determine how their phenotypes compared to the knockdown and overexpression 
studies. 
 
Missense Mutation Analysis 
 Mutant strains with homozygous mutations within pnpt-1 were identified and selected 
from the Caenorhabditis Genetics Center. Mutations were induced through EMS and ENU 
mutagens on VC2010 (N2 wildtype derivative).  Independent clonal lines were allowed to self 
proliferate, driving individual mutations to homozygosity (Thompson et. al., 2013).  Of the 24 
strains available, none of them presented nonsense mutations while all of them presented 
homozygous missense mutations in exons of the gene.  All missense mutations were analyzed 
through SIFT and Polyphen-2 software to determine the predicted effect of the mutation on gene 
function.  A score of 1 or close to 1 in Polyphen-2 predicted the mutation to be deleterious while 
a score of <0.05 in SIFT predicted the mutations to be deleterious.  Among the 24, G58E 
(VC40327), G74R (VC20261), and G74E (VC20284) were selected (Table 20).  G58E and 
G74R mutations were predicted to be deleterious or damaging while G74E was predicted to be 
benign.  G74E and G74R were selected due to differences in their predicted 
deleteriousness/benigness while having a missense mutation affecting the same amino acid.  
G58E was selected as another predicted deleterious mutant strain to serve as a comparison with 
G74R, also a predicted deleterious mutant strain.  All three mutations were found to be located in 
the first catalytic domain of pnpt-1.  These specific strains were selected to determine if 
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predicted disruption of the protein within the first catalytic RNase PH domain would affect 
normal protein function.  One study identified compound heterozygous missense mutations, one 
in the first RNase PH domain and one in the second RNase PH domain, in the PNPT1 gene that 
produced a disease phenotype (Alodaib et. al., 2016).  The RNase PH domains provide the 
exoribonuclease function of PNPase.  Although there are two RNase PH domains, selecting 
strains with mutations in the first catalytic domain would determine if the mutation affects total 
protein function, if the mutation results in reduced PNPase function as a result of disrupting the 
first RNase PH domain and not the second, and if both RNase PH domains are required for 
normal protein function.  
 Since mutant lines were generated through random mutagenesis with EMS and ENU at 
the Caenorhabditis Genetics Center, each line was backcrossed with VC2010, N2 wildtype 
derivative, for a total of eight times to generate a predicted 99.61% wildtype background to 
remove unlinked mutations located outside of pnpt-1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     74 
 
Table 20: Mutant strains available for pnpt-1.  SIFT predicted the effects of amino acid substitution on protein function.  Polyphen-
2 determined the impact amino acid substitution has on protein function and structure.  The mutants highlighted in green were used for 
this study.  A score of 1 from Polyphen-2  and a score of 0 or close to 0 identified the missense mutation as predicted to be deleterious.  
Strains with mutations located in the first catalytic RNase PH domain include gk747448, gk576099, gk327843, gk165911, gk165912, 
gk165915, and gk388087.  Strains with mutations located in the second catalytic RNase PH domain include gk165917, gk347759, 
gk360199, gk364277, gk379909, gk715189, gk779183, and gk803047.  Strains with mutations located in the S1 domain include 
otn17845, and otn7416    
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Endogenous PNPase Expression of Mutants 
 In both laboratory models and human studies, mutations located in the gene coding 
(exon) regions of pnpt-1 could reduce normal protein function and or prevent trimeric formation 
of the protein (Vedrenne et. al., 2012; Golzarroshan et. al., 2018).  Specifically, mutations in the 
second catalytic RNase PH domain resulted in lower RNA binding and degradation activities 
(Golzarroshan et. al., 2018).  Depending on the severity of the mutation, missense mutations in 
pnpt-1 have been shown to contribute to a disease phenotype in a human study setting.  Although 
the mutations were not located in the regulatory regions of the gene, PNPase expression was still 
quantified using qRT-PCR with primers that spanned the exon 9 and exon 10 junction to 
determine if PNPase expression was altered with the selected mutations.  In a comparison to 
VC2010, the N2 wildtype derivative, strains G74R, G58E, and G74E showed no significant 
difference in PNPase expression (p=0.07) (Figure 10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: PNPase Expression in Mutant Strains.  PNPase expression in mutant lines were 
not significantly different than wildtype (p=0.07) (n=3) 
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Polycistronic Transcript Accumulation 
The genome of the mitochondria is a circular piece of DNA that is transcribed as a single 
polycistronic transcript where a single mRNA can code for several proteins upon RNA 
processing into individual RNA molecules (Figure 11).  One of the enzymes responsible for 
processing polycistronic transcripts in the mitochondrion and excising intervening tRNAs is 
RNase P.  Since RNase P is one of the RNA molecules transported by PNPase, the goal of this 
experiment was to determine if mutations in PNPase affected accumulation and processing of 
polycistronic transcripts as a result of disrupted transport of RNase P RNA into the 
mitochondria.  Previous knockdown studies determined that a decrease in PNPase expression 
resulted in an increase in polycistronic transcript accumulation (Laura 2015).  To determine the 
degree of polycistronic transcripts accumulation, total mitochondrial and polycistronic transcripts 
were quantified.  This data would allow determination of percentage of polycistronic transcripts 
among total mitochondrial transcripts produced.  The amount of polycistronic transcripts were 
quantified using qRT-PCR with primers at the region between ctb-1 and COIII.  When compared 
to VC2010 wildtype worms, polycistronic transcript accumulation was not significantly different 
in the mutants (p=0.31).  Samples G58E and G74E each produced one outlier among the three 
trials that contributed to the high error bars and high variance.  G74R presented a 0.59x fold 
change, G58E presented an 8.72x fold change, and G74E presented a 10.21x fold change (Figure 
12). 
 
 
 
 
 
 
 
 
  
   
 
77 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Mitochondrial DNA Gene Map of C. Elegans.  Locations of the protein coding 
genes (gray arrows), tRNAs (circles), and rRNAs (black arrows) coded by the mitochondrial 
genome.  Genes are transcribed as a polycistronic transcript and later processed to single RNA 
species.  (From wormbook.com) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Polycistronic Transcript Accumulation.  Polycistronic transcript accumulation 
were not significantly different in the mutants when compared to VC2010 wildtype(p = 
0.31)(n=3) 
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 Total mitochondrial transcripts, both processed and polycistronic, were quantified using 
qRT-PCR by measuring the expression of COIII.   When comparing to VC2010 wildytpe, G58E 
show a trend of a large increase while G74E presented a trend of a modest increase for total 
mitochondrial transcripts (Figure 13).  Due to technical errors with the qRT-PCR protocol, the 
experiment was only attempted once and no statistical analysis was carried out.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Total Mitochondrial Transcripts measured by qRT-PCR.  Mutant strains 
presented variations in amount of total mitochondrial transcripts compared to VC2010.  No 
statistical analysis could be carried since this was a single run (n=1) and all results are presented 
as trends.    
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ROS Assay 
 ROS are produced as a by-product of cellular respiration from the respiratory chain 
complex, specifically at Complex I and III.  Large accumulation of ROS can damage proteins, 
lipids, and DNA while low accumulation of ROS can serve as activators for signaling pathways.  
Previous work on knockdown of PNPase expression through RNAi concluded that decreased 
PNPase expression correlated with an increase in ROS production (Lambert 2015).  The purpose 
of this experiment was to determine if mutations in PNPase altered ROS production and when 
compared to the VC2010 wildtype. 
 ROS production was quantified using the Amplex Red kit that served as an assay for 
quantifying peroxidase activity when !"#", a reactive oxygen species, was present.  Specifically, 
in the presence of a peroxidase, the Amplex Red Reagent reacts with !"#"in a 1:1 ratio to 
produce resorufin, a red fluorescent oxidation product.  Resorufin production could be quantified 
by absorbance since the product had an excitation and emission spectrum of 571 nm to 585 nm.  
As result, the absorbance values produced are listed as followed: 0.018 for VC2010, 0.021 for 
G74R, 0.022 for G58E, and 0.025 for G74E.   ROS production in the 3 mutants was not 
significantly different than wildtype (p=0.61) (Figure 14). 
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Figure 14: ROS production in Mutant Strains.  ROS production analysis in mutant strains 
showed no difference when compared to the VC2010 wildtype (p = 0.61)(n=3).  
 
 
Overexpression Studies 
 The goals of the overexpression studies were to generate an overexpression animal model 
in C. elegans, observe the phenotypic effects PNPase overexpression, and compare it to the 
results from the knockdown and mutant studies.  Initial attempts to clone the pnpt-1 gene into the 
pPD49.83 vector failed.  Multiple variations and protocol optimizations to clone pnpt-1 included 
using different competent cells and adjusting transformed bacteria growth conditions, but none 
worked.  It was concluded that a 3` fragment of pnpt-1 was toxic to the bacterial competent cells. 
As a result, Fusion PCR allowed for ligation of the individual fragments of pnpt-1, and the hsp-
16.41 promoter and unc-54 3` UTR from the pPD49.83 vector without propagation in E. coli.  
Ligation of the individual components occurred at overlapping regions of each fragment to 
produce a linear construct for heat shocked induced expression of exogenous PNPase.  
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Generation of Transgenic Lines 
 Transgenic strains of C. elegans were generated to create an overexpression model of 
PNPase.  Upon completion of the PCR Fusion construct of pnpt-1, equimolar amounts of 
construct and pTG96 plasmid or empty vector control pPD49.83 and pTG96 plasmid were 
microinjected in the gonad arms of VC2010 and CF3152 strains.  Transgenic VC2010 lines 
would serve as a comparison to both wildtype and mutants lines.  CF3152 strains were 
microinjected to be later used for the cancer model studies through knockdown of gld-1with 
RNAi.  pTG96 is a sur-5::GFP injection marker that allows GFP expression in somatic cells, 
serving as a tool to determine the success of transgenic strain synthesis.  Microinjected worms 
were first selected for GFP expression and singled to generate individual lines.  Individualized 
lines were allowed to propagate for at least three generations to obtain stable lines. Lines that 
maintained GFP expression were selected for maintenance of transgenic lines and for subsequent 
experiments (Figure 15, Table 21).  As a result, progeny of the microinjected worms were 
successfully transgenic and stable with consistent expression of GFP.   
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Figure 15: Adult and young adult transgenic C. elegans.  GFP expression is visible 
throughout the body length of the nematode due to the sur-5 promoter in pTG96 in VC2010 and 
CF3152 animals. 
 
 FSN PCR/TG96 pPD 49.83/TG96 
VC2010 VC2010 FSN 5A1 VC2010 pPD 1D3 
 VC2010 FSN 9C3 VC2010 pPD 4C2 
 VC2010 FSN 3D1 VC2010 pPD 13B3 
CF3152 CF3152 FSN 3B3 CF3152 pPD 3A1 
 CF3152 FSN 3B5  
 
Table 21: pnpt-1 Transgenic lines.  FSN represented transgenic lines with the Fusion PCR 
construct for exogenous PNPase expression.  pPD represented transgenic lines with the pPD 
49.83 empty vector control.  Strains in bold were used in subsequent assays 
 
 
Determination of Heat Shock Protocols 
 The Fusion PCR construct contains a hsp-16.41 promoter that can activate transcription 
upon heat stress (Stringham et. al., 1991).  Previous studies have identified the optimal 
temperature range to activate transcription with adequate response was 29°C to 31°C.  Heat shock 
temperatures could be as low as 25°C but with only ~1% of cells showing activation of transgene 
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expression (Stringham et. al., 1991).  For the protocol, researchers have determined that two two-
hour exposures with a 30 minute recovery period at 20°C was ideal. 
 Our goal was to identify a temperature and protocol that would activate the hsp-16.41 
promoter for ectopic expression of pnpt-1 without killing the nematode.  The experiment 
compared two protocols: heat shock at 30°C for two 2 hour intervals with a 30 minute recovery 
period at 20°C and heat shock at 30°C for one 2 hour interval (Stringham et. al., 1992).  We used 
qRT-PCR to measure FLAG TAG expression for exogenous PNPase to compare the two 
protocols.  Both treatment conditions resulted in induction of exogenous PNPase expression.  In 
both VC2010 FSN 9C3 and CF3152 FSN 3B3 transgenic lines with the Fusion PCR construct, 
there was a larger increasing trend for exogenous expression of PNPase with the two 2 hour 
interval at 30°C compared to one 2 hour interval at 30°C.  When compared to the values from one 
2 hour heat shock interval, VC2010 FSN 9C3 resulted in a 318.6% increase and CF3152 FSN 
3B3 resulted in a 90.6% increase with 2 intervals of heat shock (Figure 16).  This was attempted 
once for protocol determination only, thus no statistical analysis can be provided.  Moving 
forward, the heat shock protocol for subsequent overexpression experiments followed the two 2 
hour interval at 30°C. 
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Figure 16: Exogenous PNPase Expression Under Two Heat Shock Protocols.  Transgenic 
lines VC2010 FSN 9C3 and CF3152 FSN 3B3 produced higher expression of exogenous PNPase 
with two two-hour intervals at 30°& when compared to one two-hour heat shock interval at 30°&.  
With two two-hour intervals, VC2010 resulted in a 166x fold change and CF3152 resulted in a 
112x fold change compared to their non-heat shocked counterparts (n=1)    
 
 
Exogenous pnpt-1 Expression 
 While the transgenic strains visibly expressed the co-injection GFP maker under a 
fluorescent microscope, qRT-PCR experiments measuring FLAG TAG expression for ectopic 
PNPase would allow confirmation of successful creation of an overexpression model.  Among 
the three heat shocked VC2010 FSN PCR transgenic lines and one heat shocked CF3152 FSN 
PCR transgenic line, all four presented an increase for FLAG Tag expression for exogenous 
PNPase in comparison to their non-heat shocked transgenic controls.  Heat shocked VC2010 
FSN 5A1 had 130x higher expression, heat shocked VC2010 FSN 9C3 had 130x higher 
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expression, heat shocked VC2010 FSN 3D1 had a 348x higher expression, and heat shocked 
CF3152 FSN 3B3 had 161x higher expression.  Statistical analysis concluded that VC2010 FSN 
5A1 (p = 0.045), VC2010 FSN 9C3 (p = 0.006), and CF3152 FSN 3B3 (p = 0.012) strains 
produced a significant increase in expression for exogenous PNPase while VC2010 FSN 3D1 (p 
= 0.192) was not significant (Figure 17).  In subsequent experiments and assays, VC2010 FSN 
9C3 and CF3152 FSN 3B3 were selected as the two transgenic lines to use for overexpression 
studies.   
 Transgenic lines for the empty vector control (pPD49.83) showed no fold change in 
FLAG Tag expression when heat shocked lines were compared with their non-heat shocked 
controls (data not shown).  Transgenic lines VC2010 pPD 1D3 and CF3152 pPD 3A1 were used 
as controls for future experiments and assays.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: FLAG Tag Expression in Transgenic Lines.  Significant increase in fold change 
was determined for exogenous PNPase expression in heat shocked VC2010 FSN 5A1 (p = 
0.045), VC2010 FSN 9C3 (p = 0.006), and CF3152 FSN 3B3 (0.012) when compared to their 
non-heat shocked counterparts.  Increase in FLAG Tag expression in heat shocked VC2010 FSN 
3D1 was not significant (p = 0.192) (n=3) 
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Total (Endogenous and Exogenous) pnpt-1 Expression 
 The next step was to determine the difference in total PNPase expression between FSN 
and pPD transgenic lines that were heat shocked and not heat shocked.  The goal was to identify 
how much exogenous PNPase contributed to total PNPase expression.  qRT-PCR was used to 
measure total PNPase, both endogenous and exogenous, using primers spanning the junction of 
exon 9 and exon 10 of pnpt-1.  All heat shocked lines that contained the Fusion PCR construct 
produced significantly more total pnpt-1 expression than non-heat shocked controls.  Heat 
shocked VC2010 FSN 5A1 had 57x increase, heat shocked VC2010 FSN 9C3 had 100x increase, 
heat shocked VC2010 FSN 3D1 had 128x increase, and heat shocked CF3152 FSN 3B3 had 
127x increase in total PNPase expression.  Heat shocked FSN transgenic lines produced a 
significant increase in fold change for total PNPase expression compared to non-heat shocked 
FSN transgenic lines (p = 0.0004).  Heat shocked CF2010 pPD 4C2  had 1.1x increase, heat 
shocked VC2010 pPD 1D3 had 1.61x increase, heat shocked VC2010 pPD 13B3 had 1.11x 
increase, heat shocked CF3152 pPD 3A1 had 1.27x increase, and heat shocked CF3152 pPD 
5A1 had 1.01x increase in total PNPase expression.  Heat shocked pPD transgenic lines fold 
changes were not statistically significant when compared to their non-heat shocked pPD 
transgenic lines (p = 0.79) (n=3) (Figure 18).   
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Figure 18: Total pnpt-1 Expression in Heat Shocked Transgenic lines.  All four transgenic 
lines with FSN PCR constructs showed significant increase in total PNPase expression when 
heat shocked (p = 0.0004).  pPD transgenic lines showed no significant difference in pnpt-1 
expression when heat shocked (p = 0.79) (n=3) 
 
Exogenous PNPase Expression 
 Following qRT-PCR analysis for FLAG Tag expression in transgenic lines, the next step 
was to determine if heat shock activation for exogenous PNPase expression resulted in 
exogenous PNPase protein formation.  Western blot analysis was carried out using FLAG TAG 
M2 antibody to detect exogenous PNPase since the FSN construct contained a triple FLAG Tag 
at the C-terminus.  Results indicated that only FSN transgenic lines that were heat shocked 
produced flag-tagged PNPase (Figure 19). 
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Figure 19: Exogenous PNPase Expression. Heat shocked FSN Transgenic lines resulted in 
exogenous PNPase protein production that was detected through a FLAG Tag antibody. The 
vector control pPD did not show any exogenous PNPase expression (n=3). 
 
Polycistronic Transcript Accumulation  
To determine if increased expression of PNPase influenced polycistronic transcript 
accumulation in the mitochondria, qRT-PCR was carried out measuring polycistronic transcript 
accumulation using primers at the junction between the ctb-1 and COIII genes.  Heat shocked 
VC2010 FSN 9C3 produced an 165.5% (2.66x fold change) increase in polycistronic transcript 
accumulation while heat shocked CF3152 FSN 3B3 resulted in a 75.6% (0.24x fold change) 
decrease in polycistronic transcript accumulation when compared to their non-heat shocked 
counterparts.  Statistical analysis determined the results for heat shocked VC2010 FSN 9C3 (p = 
0.0006) and CF3152 FSN 3B3 (P < 0.0001) were significant.  Heat shocked VC2010 pPD 1D3 
resulted in an 8% increase in polycistronic transcript accumulation (1.08x fold change) and heat 
shocked CF3152 pPD 3A1 resulted in a 192% increase (2.92x fold change) but was not 
significantly different than its non-heat shocked counterpart.  Heat shocked empty vector pPD 
transgenic polycistronic transcript accumulation were not significantly different than their non-
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heat shock counterparts for VC2010 pPD 1D3 (p = 0.7511) and CF3152 pPD 3A1 (p = 0.08) 
(n=3) (Figure 20).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: Polycistronic transcript accumulation in Heat Shocked Transgenic Lines.  Heat 
shocked VC2010 FSN 9C3 presented significant increase in polycistronic transcript 
accumulation (p = 0.0006).  Heat shocked CF3152 FSN 3B3 presented significant decrease in 
polycistronic transcript accumulation (p < 0.0001).  Heat shocked empty vector controls resulted 
in no significant change for polycistronic transcript accumulation. (n=3) 
 
Total Mitochondrial Transcript 
 Total mitochondrial transcripts were quantified using qRT-PCR by measuring the 
expression of COIII.  Heat shocked transgenic lines were compared with their non-heat shocked 
counterparts.  Heat shocked VC2010 FSN 9C3 produced a large trend for increased total 
mitochondrial transcript while CF3152 FSN 3B3, VC2010 pPD 1D3, and CF3152 pPD 3A1 
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resulted in small trends for increased transcripts (Figure 21).  Due to technical errors with this 
protocol, the experiment was attempted only once so no statistical analysis can be provided. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: Total Mitochondrial Transcripts in Heat Shocked Transgenic Lines.  Increased 
trends in total mitochondrial transcripts was present in heat shocked transgenic strains. (n=1)  
 
ROS Assay 
Previous work in cell lines determined that overexpression of PNPase resulted in an 
increase of ROS production as a result of induced senescence (Sarkar et. al., 2004).  The purpose 
of this experiment was to determine if overexpression of PNPase as a result of exogenous 
PNPase activation could change ROS production in heat shocked transgenic nematodes.  ROS 
production was quantified using the Amplex Red kit that served as an assay for quantifying 
peroxidase activity when !"#", a reactive oxygen specie, was present.  In a comparison between 
heat shocked and non-heat shocked strains, most of the strains saw no varying trends in 
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absorbance changes when strains were heat shocked with the exception of VC2010 FSN 9C3.  
Heat shocked VC2010 FSN 9C3 saw a 50.4% decrease in ROS production, heat shocked 
CF3152 FSN 3B3 saw a 2.6% increase in ROS production, heat shocked VC2010 pPD 1D3 
resulted in an 8.77% decrease in ROS production, and heat shocked CF3152 pPD 3A1 resulted 
in a 13.89% increase in ROS production.  Statistical analysis for VC2010 FSN 9C3 (p = 0.19), 
CF3152 FSN 3B3 (p = 0.95), VC2010 pPD 1D3 (p = 0.55), and CF3152 pPD 3A1 (p = 0.82) 
determined the results to be not significant (n=3) (Figure 22).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: ROS Production in Heat Shocked Transgenic Lines.  Results between heat 
shocked and non-heat shocked transgenic lines varied little across different transgenic strains.  
Statistical analysis revealed no significant differences between treatment groups (VC2010 FSN 
9C3 (p = 0.19), CF3152 FSN 3B3 (p = 0.95), VC2010 pPD 1D3 (p = 0.55), CF3152 pPD 3A1 (p 
= 0.82) (n=3). 
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Cancer Model Studies  
 The goal of the cancer model studies was to combine the PNPase overexpression model 
in a gld-1 knockdown cancer model nematode and to determine if PNPase overexpression 
differentiates cells into non-germline cells in the nematode germline 
 
Heat Shock Protocol Optimization for Cancer Models 
 Protocol to heat shock transgenic worms was optimized for both temperature and 
duration in order to produce exogenous PNPase expression over a 2-day period during 
knockdown of gld-1 without killing the nematode.  qRT-PCR measuring FLAG Tag expression 
for exogenous PNPase in the CF3152 FSN 3B3 transgenic strain identified a suitable heat shock 
protocol produced the most exogenous PNPase.  Adult nematodes were heat shocked at 26.5°C 
or 27.2°& for a 24-hour period or heat shocked at 30°C for two 2 hour intervals with a 30 minute 
break at 20°C in between.  Heat shock protocols at 26.5°C or 27.2°C resulted in an increased fold 
change by 339X and 423X, respectively, but when the nematodes were heat shocked at 30°C 
produced the highest fold change trend at 4564X (Figure 23).  Statistical analysis could not be 
conducted since this was attempted only once for protocol optimization.  The final heat shock 
protocol for subsequent gld-1 cancer experiments consisted of two 2 hour intervals at 30°C 
separated by a 24 hour period between each interval.   
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Figure 23: Exogenous PNPase Expression in Heat Shocked CF3152 FSN 3B3 strain.  When 
animals were heat shocked at 30°& there was an 4564X increase compared to their non-heat 
shocked counterpart.  Heat shocked the animals at 26.5°& or 27.2°& produced a smaller increase. 
(n=1) 
 
Oocyte Formation 
 gld-1 knockdown in C. elegans produces a cancer phenotype that results in massive 
mitotic proliferation throughout the germline and ablation of oocyte production (Kirienko et. al., 
2014).  Overexpression of PNPase induces a senescent-like phenotype that arrest cells in G1 
phase of the cell cycle and inhibits growth in HO-1 cell lines (Sarkar et. al., 2003).  The goal was 
to determine if overexpression of PNPase prevents the gld-1 overproliferation phenotype through 
senescent inducing mechanisms.  gld-1 knockdown nematode strains were heat shocked, oocyte 
production quantified and compared to their non-heat shocked control.   There was no difference 
in oocyte production with PNPase overexpression. Though heat shocked CF3152 FSN 3B3 
resulted in a 8.47 increase in oocyte producing worms (p = 0.16), heat shocked CF3152 pPD 
  
   
94 
3A1 resulted in a 25.19% increase (p = 0.16), and heat shocked CF3152 resulted in a 7.96% 
decrease (p = 0.76), though there was no statistical difference (Figure 24).  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24: Oocyte Production in Heat Shocked Animals. There was no difference in oocyte 
production in both FSN, pPD transgenic lines or CF3152 controls when.  Results were not 
statistically significant (CF3152: p = 0.76, CF3152 pPD 3A1: p = 0.16, CF3152 FSN 3B3: p = 
0.16) (n=3) 
 
P-Granule Immunohistochemistry 
 The regulatory regions of the Fusion PCR construct consisted of the hsp-16.41 promoter 
and the unc-54 3` UTR that allow expression in most somatic cells and within late pachytene of 
the nematode germline.  Knockdown of gld-1 not only creates a cancer model with mass mitotic 
proliferation throughout the germline but also development of somatic cells such as muscle, 
neuronal, and intestinal cells within the gonad (Ciosk et. al., 2006).  K76, antibody to PGL-1, 
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would detect p-granules through immunofluorescence, serving as a marker specific for germline 
cells in the nematode gonad.  Immunofluorescence of the germline would determine if 
overexpression of exogenous PNPase would inhibit or reduce severity of gld-1 cancer phenotype 
and increase the number of non-germline cells within the gonad through induction of senescence 
or differentiation.   
Strains used for immunofluorescence consisted of CF3152 with and without heat shock, 
CF3152 pPD 3A1, and CF3152 FSN 3B3 with the same treatment.  All gonads were co-stained 
with K76 and FLAG Tag antibodies to detect germline specific cells and exogenous PNPase, 
respectively.  All six strains presented staining for K76, a marker that is targeting guanyl-specific 
ribonuclease pgl-1 that is found exclusively in germline cells, from the distal to proximal end of 
the germline (Figure 25-30), and no oocyte production with the exception of one case in CF3152 
FSN 3B3 no heat shock (Figure 29).  Exogenous PNPase expression was only observed in 
CF3152 FSN 3B3 when it was heat shocked (Figure 30).  Gonads in this heat shocked strain 
displayed cells that presented FLAG Tag expression with no K76 colocalization.  No staining for 
K76 in those cells determined that those are non-germline cells.  It was also determined that heat 
shock treatment and empty vector pPD49.83 had no effect on the tumerous phenotype of the  
gld-1 cancer model.    
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Figure 25: Oocyte Development of gld-1 KD CF3152 Control Worms. Gonad of CF3152 no 
heat shock at 20x magnification shows no oocyte formation in the proximal gonad (blue and 
purple boxes_ with K76 staining present from distal to proximal in the germline (red through 
purple boxes).  No FLAG Tag staining indicates no exogenous PNPase expression (red through 
purple boxes). Blue is DAPI staining, green is K76 and red is FLAG-tag PNPase (20x mag) 
(n=1). 
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Figure 26: Oocyte Development of gld-1 KD CF3152 with Heat Shock. Gonad of CF3152 
with heat shock shows no oocyte formation in the proximal gonad (blue and purple boxes) with 
K76 staining present from distal to proximal ends of the germline (red through purple boxes).  
FLAG Tag PNPase staining was not detected indicating no exogenous PNPase expression (red 
through purple boxes). Blue is DAPI staining, green is K76 and red is FLAG-tag PNPase (40x 
mag) (n=3) 
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Figure 27: Oocyte Development of gld-1 KD CF3152 pPD 3A1 no Heat Shock.  Gonad of 
CF3152 pPD 3A1 with no heat shock shows no oocyte formation (blue and purple boxes) in the 
proximal gonad with K76 staining present from distal to proximal ends of the germline (red 
through purple boxes).  No FLAG Tag detection indicates no exogenous PNPase expression (red 
through purple boxes). Blue is DAPI staining, green is K76 and red is FLAG-tag PNPase (40x 
mag) (n=1) 
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Figure 28: Oocyte Development gld-1 KD CF3152 pPD 3A1 with Heat Shock. Gonad of 
CF3152 pPD 3A1 with heat shock shows a large cellular body with chromatin morphology 
suggesting oocyte formation or meiotic division in the middle of the germline (light blue box). 
K76 staining is present from distal to proximal ends of the germline with the exception of the 
large body singular cell (red, yellow, green, purple boxes).  No FLAG Tag detected indicating no 
exogenous PNPase expression (red through purple boxes). Blue is DAPI staining, green is K76 
and red is FLAG-tag PNPase (40x mag)(n=2) 
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Figure 29: Gonad of gld-1 KD CF3152 FSN 3B3 Without Heat Shock. While oocyte 
development appears to be replaced with mitotic divisions in the proximal region of gonad due to 
gld-1 knockdown (red box), the proximal gonad contained a large mononuclear structure with no 
K76 staining (blue and purple boxes).  No FLAG Tag staining present throughout the germline 
(red through purple boxes). Blue is DAPI staining, green is K76 and red is FLAG-tag PNPase 
(20x mag) (n=4)  
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Figure 30: Gonad of gld-1 KD CF3152 FSN 3B3 with Heat Shock.  FLAG Tag staining (red) 
was observed to be present in the germline (yellow and purple boxes).  Cells within the region of 
FLAG Tag staining did not present K76 staining (green) (yellow and purple boxes).  At the 
proximal end of the gonad (purple box), FLAG Tag staining appeared to localize around DAPI 
stained DNA (blue).  No oocyte formation was present in the germline (red through purple 
boxes).  K76 staining was present from the distal to proximal ends (orange through purple boxes) 
with the exception of cells at the very distal tip of the germline (red box) and cells colocalized 
with FLAG Tag expression for ectopic PNPase expression (yellow and purple boxes)  (whole 
germline = 20x mag | cut outs = 100x mag) (n=1) 
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Chapter 4: Discussion 
Phenotypic characterization of overexpression and knockout of PNPase has been restricted to 
models such as cell lines or organ specific models, limiting the conclusions that can be drawn 
with regard to the organism as a whole.  Additionally, no whole animal model for PNPase 
overexpression has been produced.  Formation of an animal model for overexpression and 
characterization of PNPase mutants, with the already synthesized knockdown model in C. 
elegans (Lambert 2015), would allow direct comparison of the phenotypic effects of reduced and 
increased PNPase levels on both a gross and molecular scale.  Analysis of PNPase mutants 
would determine if the selected missense mutations impair protein function and contribute to a 
disease phenotype.  Having these models would allow correlation of previous PNPase findings in 
ROS, and mitochondrial homeostasis mechanisms and how they present in an animal model 
setting.  A model for PNPase overexpression would also allow investigation into associated 
senescent inducing and differentiation mechanisms in a whole animal cancer model.   
In this study, the first step was to create an overexpression and mutant models for PNPase in 
C. elegans.  Then, ROS production and mitochondrial homeostasis through polycistronic and 
total mitochondrial transcript accumulation were measured in PNPase knockdown, mutants, and 
overexpression.  Qualitative analysis through immunofluorescence was utilized to observe the 
influence of ectopic PNPase overexpression on germline tumor cells in a cancer model setting.  
 
Knockdown Studies 
 RNAi mechanisms to knockdown gene expression in C. elegans produced a decrease in 
PNPase expression but were inconsistent with each experiment when attempting to confirm 
previous studies (see Appendix).  When RNAi mechanisms did work, the results matched 
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previous reports that noted a 63% reduction in mRNA expression (Lambert 2015).  
Inconsistencies in achieving knockdown expression could have been attributed to not using the 
freshest reagents, plates, and bacteria.  However, even when using the freshest reagents and 
stocks, knockdown of PNPase was only achieved 3 out of 6 times.  Although inconsistent with 
PNPase expression, knockdown of dpy-10 to produce the dumpy phenotype as a control was 
consistently seen with each RNAi attempt.  This suggests that the RNAi protocol is capable of 
knocking down gene expression for dpy-10.  Issues for Exon 3 knockdown could be inefficiency 
of the IPTG inducer for activated transcription and production of dsRNA of Exon 3 or growth of 
antibiotic resistance bacteria in the same RNAi culture, reducing the knockdown effect.  A 
previous report had indicated that despite using the most optimal RNAi technique for 
knockdown expression (consumption of bacteria expressing dsRNA with 1mM IPTG inducer in 
the plate media instead of bacteria culture), phenotypic variability of RNAi penetrance was 
present for different gene targets (Kamath et. al., 2001).  This could explain why dumpy 
phenotype with knockdown of dpy-10 was consistent while knockdown of PNPase was not.   
ROS were quantified as a means to determine PNPase effects on mitochondrial 
homeostasis.  In addition to ROS being produced as a byproduct of cellular respiration, aging 
cells are associated with production of high levels of ROS from the mitochondria that cause 
damage to protein, lipids, and DNA (Davali et. al., 2016).  ROS mediates senescence through 
accumulation of damage and contributes to the induction of replicative senescence, limiting the 
number of divisions a cell can undertake (Chen et. al., 1998; Passos et. al., 2010).  In addition to 
onset of senescence, ROS also functions in a positive feedback loop mechanism to maintain the 
senescent phenotype (Takahashi et. al., 2006).  These findings suggest ROS plays a large role in 
senescence. 
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 Knockdown of PNPase resulted in an increased trend in ROS production (appendix) in 
agreement with previous knockdown studies (Lambert 2015).  Lack of significance of the results 
could be attributed to inconsistencies in producing knockdown of PNPase through RNAi 
mechanisms.  Previous studies identified a near 50% increase in ROS production in knockdown 
of PNPase compared to the control (Lambert 2015).  While a large increase in ROS production 
induced and maintained senescence, our findings presented a slight increase in ROS production 
that could be attributed to activation of beneficial stress responses that influence extension of 
lifespan.  Additionally, a low increase of ROS can activate signaling pathways leading to 
proliferation and transcription (Trachootham et. al., 2008; Thannickal and Fanburg, 2000).  
Previous lifespan studies have reported that knockdown of PNPase resulted in an extension of 
lifespan.  It was hypothesized that the slight elevation of ROS production could have activated 
beneficial stress responses to influence extension of lifespan (Lambert 2015).  However, to 
determine if this level of increased ROS imparted beneficial responses such as lifespan 
extension, a lifespan assay comparing knockdown, mutants, and overexpression profiles of      
pnpt-1 would be required.   
 Polycistronic and total mitochondrial transcripts were measured to assess the role of 
PNPase in transporting RNase P RNA, an exoribonuclease responsible for processing 
mitochondrial tRNAs, in the mitochondria.  The mitochondrial genome is a circular piece of 
DNA that is transcribed as a single polycistronic transcript where a single mRNA can code for 
several proteins upon RNA processing.  Amounts of both polycistronic and total mitochondrial 
transcripts were determined through qRT-PCR.  It was expected that our knockdown studies 
would produce similar results as the previous knockdown studies with an increase in 
polycistronic transcript accumulation.  Knockdown of PNPase saw a decrease trend in both 
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polycistronic transcripts and total mitochondrial transcripts but results were not significant.  
Previous studies concluded that PNPase knockdown through RNAi mechanisms resulted in an 
increase in polycistronic transcript by 66 fold.  It was suggested that reduced expression of 
PNPase would decrease the rate of transport of RNase P RNA to the mitochondria, leading to 
increased accumulation of polycistronic transcripts due to improper splicing of mitochondrial 
transcript (Lambert 2015).  Even with confirmation of knockdown of PNPase expression, our 
findings contradict previous studies.  However, since our results were not statistically significant, 
we were unable to conclude if polycistronic transcript accumulation decreases with knockdown 
of PNPase.  Results produced could be attributed to a reduced but functional level of PNPase 
expression even though knockdown of PNPase expression occurred.  The residual level of 
PNPase expression could allow transport of RNase P RNA to the mitochondria, thus allowing 
processing of polycistronic transcripts and a decrease in its accumulation.   
For future directions, optimization of RNAi protocol could be carried out to improve 
penetrance of the knockdown phenotype.  Such changes could include increasing IPTG inducer 
to 1 mM and adding it to the worm plate rather than in the bacterial cultures, and grow liquid 
cultures without induction and allow seeded cultures to grow at room temperature (Kamath et. 
al., 2001).  Additionally, comparisons could be made between staging worms at the L4 stage 
versus staging embryos to determine which protocol produces the greatest knockdown effect. 
 
Mutant Studies 
 Previous studies of mutations in PNPase in cultured skin fibroblasts saw a 50-60% 
decrease in PNPase protein but no change in PNPT1 transcripts (Vedrenne et al., 2012). 
Researchers identified a disruption in the trimerization of the protein when the missense 
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mutation was located in the second RNase PH catalytic domain (Vedrenne et. al., 2012).  Our 
findings were consistent with previous reports but were limited to pnpt-1 transcripts.  We found 
that pnpt-1 mRNA expression was unchanged in the mutants.  We were able to conclude that 
three specific missense mutations in the first RNase PH domain do not affect PNPase expression 
since the mutations were located in the RNase PH domain and not in a regulatory region 
associated with pnpt-1.    
 Mutant strains resulted in no significant change in ROS production compared to their 
wildtype counterpart.  Previous studies have noted that phenotypic effects from PNPase 
mutations vary and severity of functional deficits of PNPase is dependent on the severity of the 
mutation (Golzarroshan et. al., 2018; von Ameln et. al., 2012).  One study noted that a p.E475G 
missense mutation in human PNPase did not affect PNPase expression but resulted in a disease 
phenotype consisting of hearing loss (von Ameln et. al., 2012). Our results proved that these 
specific mutations in pnpt-1 produced no significant phenotypic change in ROS production, 
suggesting that these mutations were not severe.   
   All three strains with mutations in the first RNase PH domain resulted in non-significant 
changes in polycistronic transcript accumulation and mutant strains G58E and G74E resulted in 
an increase trend for total mitochondrial transcripts.  These findings suggested that certain 
mutations in PNPase could vary in their contribution to mitochondrial homeostasis.  Previous 
findings of bacterial PNPase determined that the second RNase PH domain carried out most of 
the catalytic activity of the protein, and mutations in the second domain resulted in a severe non-
functional phenotype that impaired phosphorolysis, polymerization, and exchange (Jarrige et. al., 
2002). However, mutations in the first RNase PH domain did reduce specific activity of PNPase, 
but not at the same severity or degree as the mutations in the second RNase PH domain (Jarrige 
  
   
 
107 
et. al., 2002).  Also, studies in human PNPase determined that both RNase PH domains 
possessed similar phosphorylitic properties with equal enzymatic activity.  Presence of either one 
of them was sufficient for total enzymatic activity (Sarkar et. al., 2005).  Our findings did agree 
with previous studies.  The results produced showed that mutations in the first RNase PH domain 
do not contribute to significant increase in polycistronic transcript accumulation.  This could 
partly be due to the fact that the second RNase PH domain contained no mutations and 
compensated phosphorylitic activity for the first mutated RNase PH domain.  One study 
identified a patient with two biallelic pathogenic missense variants in PNPT1 (R136C and 
P467H), one in each RNase PH domain of PNPase (Rius et. al., 2019).  When assessing PNPase 
mitochondrial RNA processing activity, investigators reported that the patient’s fibroblasts 
presented a significant increase in accumulation of unprocessed mitochondrial transcripts (Rius 
et. al., 2019).  Individual mutations could vary in degree of disrupting normal PNPase function 
without altering PNPase expression even if they were located in the first catalytic domain.  
However, conserved amino acids present in orthologs of PNPase could suggest a higher degree 
of importance as determining residues.  Mutations affecting these amino acids would be more 
likely to impart a disease phenotype.  Among the mutant strains selected, the G58E missense 
mutation occurs at a conserved residue while G74R and G74E are missense mutations in an 
unconserved residue.  Despite this, all three mutant strains did not produce a significant change 
in polycistronic transcript accumulation nor ROS production. As a result, we can conclude that 
the studied mutations in pnpt-1 do not produce a deleterious phenotype within the areas of 
polycistronic transcript accumulation, total mitochondrial transcript accumulation, and ROS 
production. 
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For future studies, using other mutant strains that contain missense mutations in the 
second catalytic RNase PH domain would determine if both catalytic domains work equally or if 
the second domain carries out most of the enzyme activity.  Additionally, there is another mutant 
strain that has a missense mutation in the S1 RNA binding domain of pnpt-1.  Using this strain 
would determine if the mutation affects RNA binding activity of PNPase and if that change leads 
to observable phenotypic effects.  Also, CRISPR could be used to knock in human mutations at 
conserved residues in wPNPT1 such as A510P and Q387R in the human studies.  Doing so could 
determine if similar phenotypes seen in human studies would be present in C. elegans.  Using 
only Polyphen-2 and SIFT for predicted effects of mutations limited our knowledge of the effect 
the missense mutations had on protein catalytic function.  Having protein structure analysis 
would give insight on the structural changes occurred and if those changes inhibit normal protein 
function.  Non denaturing or native gel electrophoresis would also determine if those mutations 
affected trimerization of the protein. 
 
Overexpression Studies 
 Creation of an overexpression model for PNPase first required design and synthesis of 
the transgenic construct.  Initial attempts at cloning PNPase into the pPD49.83 vector were not 
successful and it is likely that certain cloned fragments of pnpt-1 were toxic to transformed 
bacteria.  Varied attempts consisted of adjusting different steps of the cloning protocol to bypass 
this issue.  Different competent cells, BL21 DE3, ABLE C, and ABLE K, were used for their 
specific properties at retrieving clones that were toxic to E. Coli since initial cloning attempts 
with DH5alpha and DH10B were unsuccessful leading us to hypothesize that the fragment being 
cloned was toxic to the bacteria.  ABLE C and ABLE K strains are designed to increase the 
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probability of retrieving toxic clones by reducing the plasmid copy number.  This results in 
decreased levels of the cloned gene product and enhances the probability for toxicity to the host.  
BL21 DE3 cells have T7 RNA polymerase controlled by Lac regulatory construct that will only 
be active in the presence of IPTG, thus limiting toxic protein expression.  Temperature 
conditions were lowered and transformed bacteria were grown at room temperature (20°C - 30°C) 
for several days to reduce toxicity of the hypothetically toxic cloned gene.  Any attempt at 
cloning a 3` fragment of pnpt-1 resulted in the fragment ligating in the opposite orientation or 
ligating in the correct orientation but with mutations.  A third party manufacturer (ThermoFisher 
GeneArt Gene Synthesis) was used to design a fragment of pnpt-1 hypothesized to be toxic to E. 
coli.  While they were able to clone the fragment and synthesize the plasmid, using that pnpt-1 
fragment for subsequent ligating and cloning protocols was unsuccessful.  Gibson assembly 
protocol was also used to minimize the number of cloning and transformation steps but also 
failed.  As a result, we conclude that the 3` fragment is toxic to E. coli, thus preventing 
successful cloning of this gene.  PCR Fusion allowed for annealing of overlapping ends between 
multiple individual segments and using a two-step method to create the full-length clone (Hobert 
et. al., 2002; Luo et. al., 2012).  It was vital to use a polymerase with 3` - 5` proofreading activity 
and high fidelity to fix and prevent, respectively, sequence errors during each amplification cycle 
(Hobert et. al., 2002).  This technique allowed for bypassing of intermediate steps associated 
with cloning such as overnight cultures, mini-preps, and transformations.  As a result, generating 
the full-length clone in vitro did not require the construct to be propagated in E. coli.  This 
ultimately streamlined the assembly process.     
 Overexpression of PNPase was achieved through heat shocked protocols at two hour 
intervals at 30°C for exogenous PNPase expression.  A combination of qRT-PCRs and Western 
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blots allowed identification and differentiation of exogenous PNPase from endogenous PNPase 
due to the added 3X FLAG Tag in the Fusion PCR construct.  We determined that transcription 
activation only occurred at a certain temperature and degree of expression correlated with 
increasing temperature.  Also, heat shock activation led to protein formation of exogenous 
PNPase.  Activation the hsp-16.41 promoter minimally required a temperature of 29°C to 31°C 
while temperatures as low as 25°C saw a little as 1% of cells staining (Stringham et. al., 1991).  
Additionally, transgenic nematodes maintained at 20°C results in no transgenic expression (Bacaj 
et. al., 2007).  Our findings matched these predictions and demonstrated that heat shocked at 
30°C activated the hsp-16.41 promoter for transcription of ectopic pnpt-1 that eventually led to 
exogenous protein formation.  If there was no heat shock or if a certain temperature threshold 
was not reached, the promoter would not activate and transcription would not occur.  
Additionally, no leakage of ectopic expression could be detected when samples were not 
heashocked.  Successful activation of the hsp-16.41 produced increased expression levels of 
exogenous PNPase, thus contributing to elevated levels of total PNPase expression.  Also, these 
findings concluded that heat shocked protocols saw no significant influence in changing 
endogenous PNPase expression.   
 When pnpt-1 was induced to be overexpressed, quantification of ROS production saw no 
significant difference in any of the transgenic strains.  Previous findings determined 
overexpression of hPNPase resulted in an increase in ROS production (Sarkar et. al., 2004).  
Overexpression of PNPase also led to a senescent like growth arrest phenotype with elevated 
levels of ROS being vital for induction and maintenance of the cell senescence process (Sarkar 
et. al., 2004; Davalli et. al., 2016).  Our results did not agree with previous findings and 
suggested that the degree of overexpression of PNPase was not sufficient enough to induce a 
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senescent-like phenotype that would lead to an increase in ROS production.  One potential 
complication with this experiment is that the pnpt-1 overexpression transgene is not present in 
every cell preventing uniform expression of PNPase throughout the nematode body and instead 
resulting in a more mosaic pattern of expression.  Although the transgenic lines proved to be 
stable, extrachromosomal arrays, such as the microinjected Fusion PCR construct, can be 
unstable to cell division with varying degrees of mitotic instability and incomplete inheritance 
(Evans et. al., 2006).  Specifically, some of the disadvantages of creating extrachromosomal 
arrays through microinjection are difficulty in predicting and controlling the level of expression, 
variable expression among siblings of a single strain, and variable expression due to mitotic 
instability of the arrays (Evans et. al., 2006).  As a result, lack of uniform exogenous PNPase 
overexpression in the transgenic models would prevent induced senescence in every cell.  
Finally, we could not be seeing the same results as previous studies due to not running enough 
trials.  A different approach to allow uniform expression of exogenous wpnpt-1 in all cells and 
consistent inheritance with each generation of progeny would be to use CRISPR to insert the 
Fusion PCR construct in the C. elegans genome in a region that does not disrupt any endogenous 
gene function.  
When pnpt-1 was overexpressed, wildtype transgenic lines (VC2010) resulted in an increase 
in polycistronic transcript accumulation while rrf-3 mutant transgenic lines (CF3152) saw a 
decrease when compared to their non-heat shocked counterparts.  Total mitochondrial transcripts 
presented elevated trends in heat shocked wildtype and in heat shocked rrf-3 mutants.  Despite 
producing similar trends in total PNPase and exogenous PNPase expression, opposite results 
between transgenic wildtype and rrf-3 mutants could be due to CF3152 strains containing a rrf-3 
deletion.  The rrf-3 gene codes for an RNA dependent RNA polymerase that is involved in 
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chromatin silencing by small RNA and spermatogenesis.  While the rrf-3 deletion is often 
associated with temperature sensitivity in regards to sterility and fertility, and enhanced RNAi 
(Han et. al., 2009), deletion of this gene could also be imparting some phenotypic effect that 
leads to decreased polycistronic transcript accumulation in conjunction with overexpression of 
PNPase.  Heat shock treatment to already temperature sensitive rrf-3 mutant strains to activate 
exogenous PNPase expression could influence the onset of additional phenotypes beyond what is 
already known.   
 
Temporal Regulation of PNPase Expression in the Germline 
Exogenous PNPase expression was only detected in the nematode when the transgenic 
worm was heat shocked.  Immunofluorescence labeling for FLAG Tag in gonads for exogenous 
PNPase resulted in staining only in CF3152 FSN 3B3 transgenic worms after heat shock 
activation in the pachytene region of the nematode gonad.  Our findings matched our 
expectations that hsp-16.41 and unc-54 3` UTR both served as transcriptional and post-
transcriptional regulators that limit expression to a specific region of the gonad.  The 
combination of both the promoter and UTR spatially controlled expression of exogenous PNPase 
in cells, limiting it to cells in the late pachytene region of the gonad.  Previous studies had 
indicated that the hsp-16.41 promoter was expressed in most somatic cells with a higher 
incidence of expression in intestinal and pharyngeal tissue so was not germline specific (Merrit 
et. al., 2010).  In addition to staining in the nematode gonad, intestinal cells stained brightly for 
FLAG Tagged exogenous PNPase expression, matching with previous reports (data not shown).  
Unpublished data had observed weak expression in late pachytene of gametogenesis from the 
hsp-16.41 promoter (Merritt et. al., 2010; Bacaj et. al., 2007).  The unc-54 3` UTR restricts 
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expression to all germ cells (Merritt et. al., 2008).  These reports on spatial influence of 
transcriptional regulators were consistent with our findings of predictions of PNPase expression 
in the middle region of the gonad, approximately where pachytene occurs. 
Although FLAG Tag expression for exogenous PNPase was consistent with each attempt, 
the polyclonal antibody used created so much background in the gonad that it interfered with 
image quality.  It led to concerns that staining the germline was an artifact and not a positive 
result.  However, it was confirmed that the staining for exogenous PNPase in the germline was 
not an artifact after a monoclonal FLAG Tag antibody produced similar results (data not shown).   
PNPase Senescence or Differentiation in the Germline 
 The goal of this study was to determine if overexpression of ectopic PNPase in the 
germline would result in induction of senescence or differentiation of germline tumor cells.  
Immunofluorescence labeling for germline specific P granules and exogenous PNPase identified 
cells in the gld-1 cancer model that expressed exogenous PNPase but did not present P granule 
staining.  All six groups presented successful cancer phenotype formation with knockdown of 
gld-1.  Gonads resulted in mass mitotic proliferation from the distal to proximal end of the 
germline with no oocyte production.  Previous studies have indicated that knockdown or 
mutation of gld-1 results in brief entry of germline cells into meiosis but quickly reverting to 
mitotic proliferation.  As a result, no oogenesis nor oocytes were produced with mitotically 
proliferating cells taking its place (Kirienko et. al., 2014).  These reports were consistent with 
our findings and allowed us to conclude that gld-1 results in mitotic proliferation from distal to 
proximal ends of the germline with no oocyte development.   
  
   
114 
Only heat shocked CF3152 FSN 3B3 nematodes presented staining for exogenous 
PNPase in the middle of the gonad.  Specifically, cells that contained exogenous PNPase did not 
present P granule staining suggesting terminal differentiation of a germline tumor cell into a non-
germline cell.  PGL-1, or P granules, is a germline specific marker that is essential for fertility in 
C. elegans (Kawasaki et. al., 1998, Nayak et. al., 2004).  Previous studies had noted that 
knockdown of gld-1 resulted in development of non-germline cells in the nematode gonad.  
Specifically, 40% of gonads presented both differentiated neuronal and muscle cells and 55% of 
gonads presented differentiated neuronal cells in germline of 1.5 day adults. When differentiated, 
the cells lost P granule expression with the nuclei not resembling germline cells (Ciosk et. al., 
2006).  While the nuclei formation could not be observed to differentiate somatic and germ cell 
nuclei, these reports were consistent with our finding that exogenous PNPase induces 
differentiation into a non-germline cell.  However, the type of differentiated cell, whether it was 
a neuronal or muscle-like cell, could not be determined.  Antibodies and markers used limited 
our scope to only determining if the cell belonged in the germline or not.  Also, high 
concentration of cells as a result of the gld-1 knockdown cancer phenotype prevented individual 
cellular analysis of nuclei morphology.  Based on this, we proposed that ectopic overexpression 
of PNPase has a role in differentiation inducing mechanisms in a tumor setting.   
 While the initial data look promising, additional attempts need to be carried out to 
determine a consistent and significant result.  Additionally, our experimental design allows us 
only to determine if germline cells differentiated into non-germline cells.  It does not allow 
confirmation if the differentiated cells are senescing or not.  While long term exit from the cell 
cycle is the main marker for cellular senescence, terminal differentiation results in replicative 
arrest triggered by physiological cues while cellular senescence withdraws from the cell cycle as 
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a result of activation of tumor suppressor networks and other associated factors (Kuilman et. al., 
2010).  Another encountered shortcoming occurred when using gld-1 knockdown cancer models.  
The gonads of these models were extremely brittle and prone to bursting and ripping upon 
dissection.  Also, the cancer model gonads had a greater tendency to wash off the Poly-L-Lysine 
coated slides than wildtype gonads.  Analyzing and locating individual cells in the proximal 
region of the gonad for differentiated non-germline cells proved to be unfeasible.  Large 
concentrations of mitotically dividing cells prevented individual cellular analysis, making it 
difficult to determine if P granule staining was present or not. 
For future cancer model experiments, using the double knockdown cancer model, gld-1 
and mex-3 in N2 worms has been reported to produce a higher incidence of non-germline cells 
compared to only gld-1 knockdown worms (Ciosk et. al., 2006).  Using the V2010 FSN 9C3 
transgenic line, strain synthesized from the N2 wildtype derivative, with gld-1 and mex-3 
knockdown should produce a modest over proliferation phenotype rather an extreme one that 
inhibited individual cellular analysis.  Rather than solely relying on K76, P granule antibody, to 
differentiate between non-germline and germline cells, using antibodies for UNC-119 or HLH-1 
would allow detection of neuronal or muscle like cells, respectively.  This would provide 
quantifiable results and determine if overexpression of PNPase induces a higher incidence of 
non-germline cell differentiation.   
 Since hsp-16.41 expression was greatest in intestinal and pharyngeal tissue, using a 
cancer model that causes hyperplasia in those tissues would be advantageous.  Such cancer 
models include lin-35;fzr-1 double mutants, and gain of function mutations in cdc-25.1 for 
hyperplasia in intestinal tissue (Kirienko et. al., 2014).  Rather than relying on higher heat shock 
temperatures and the associated risk of killing the worms, it would be easier to achieve higher 
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levels of exogenous PNPase in these tissue regions with the current heat shock protocol.  
Examples of protocols include heat shock treatment at 33°C for two 2 hour intervals with a 30 
minute break at 20°C inbetween (Stringham et. al., 1992) or 34°C for 30 minutes (Bacaj et. al., 
2007).  Reports for the second protocol indicated presence of the transgene product up to 24 
hours post heat treatment (Bacaj et. al., 2007).      
 
Additional Future Directions 
 Future directions for phenotypic analysis of varied PNPase expression would include 
optimizing current protocols and adding new ones.  For current protocols, qRT-PCR for 
polycistronic transcript accumulation and the ROS assay require optimization.  Designing and 
testing new primer designs for the ctb-1 and COIII junction to measure polycistronic transcripts 
would determine if the machine errors are a result of primer design.  For the ROS assay, 
increasing the number of worms per sample to 100 would allow direct comparison with the 
previous studies.  Ultimately after optimization, multiple trials, or a minimum of three trials, of 
each experiment need to be performed to allow statistical analysis.  
 Other experiments to analyze phenotypic effects from varied PNPase expression would 
include analysis of mitochondrial morphology, identification of markers of senescence in 
nematode, and quantification of 8-hydroxyguanin (8-oxoG) RNA molecules to correlate PNPase 
and its role in protecting against oxidative stress.  Analysis of mitochondrial morphology would 
allow more correlations to be drawn between PNPase expression and mitochondrial homeostasis.  
Also, it would allow direct comparison with previous knockdown studies.  Although 
overexpression of exogenous PNPase is confirmed, using markers for senescence would assess 
the senescent inducing phenotype associated with PNPase such as age-dependent increased 
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expression of lysosomal enzymes, acid phosphatase, beta-N-acetyl-D-glucosaminidase, beta-D-
glucosidase, and alpha-D-mannosidase (Bolanowski et. al., 1983). 
Rather than solely quantifying ROS, recent studies in Escherichia coli have identified 
PNPase to function as a protector against oxidative stress.  PNPase specifically binds to synthetic 
RNA containing oxidative lesions called 8-oxoG, suggesting a role in removing oxidative 
damage (Wu et. al., 2009).  8-hydroxyguanine is an oxidized form of guanine that has potential 
to pair with both adenine and cytosine at equal efficiencies, causing translational errors if this 
molecule was present in messenger RNA.  Additionally, 8-oxoguanine can cause mispairing 
during DNA synthesis (Hayakawa et. al., 2001).  RNA oxidation can be quantified to determine 
the degree of accumulated oxidative damage in each expression profile of PNPase. These 
experiments will provide better insight on PNPase function and association with mitochondrial 
homeostasis.  
In addition to identifying phenotypes associated with varied expression and mutation of 
PNPase, further experiments can be carried out to investigate molecular mechanisms of PNPase 
on these phenotypes.  RNA-seq can be used with different expression profiles of PNPase to 
analyze the C. elegans transcriptome of gene expression patterns encoded within RNA to 
identify which genes are differentially expressed and are influenced by PNPase.  Co-
immunoprecipitation for protein-protein interactions can be used to determine if mutations in 
PNPase affect protein binding activity to helicase SUV3, which forms a complex to carry out 
mitochondrial RNA surveillance.  Immunofluorescence can also be used to determine if 
localization of PNPase is affected within a cell when the protein is overexpressed, knocked 
down, or mutated.  
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Chapter 5: Conclusion 
 The mutant studies confirmed that different functional deficits of PNPase is dependent on 
the severity of the mutation.  For our specific mutant strains, results suggest that these mutational 
changes do not affect PNPase function.  Although PNPase expression was not altered in strains 
containing the mutation, the mutation appeared to not have contributed to protein function within 
the realms of ROS production, and polycistronic and total mitochondrial transcript accumulation 
with all mutant studies data presenting non significant results.  For knockdown studies, trends 
observed with ROS production was similar with previous studies.  However, inconsistencies and 
contradictions with previous data in regard to polycistronic transcript accumulation require 
further optimization and testing to determine a significant trend.  Our studies have produced a 
stable transgenic overexpression model for PNPase that presented exogenous PNPase expression 
in transgenic lines upon heat shock activation.  In a cancer setting with this model, germline cells 
expressing ectopic PNPase did not present P granule staining, suggesting differentiation into a 
non-germline cell type.  This finding expands on the differentiating inducing mechanisms 
associated with PNPase.  Although much of the data was not statistically significant, creation and 
confirmation of a working overexpression animal model for PNPase provides a strong 
foundation in better understanding protein functions, and its role in cancer.   
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Appendix: Supplementary Protocols and Information 
 
NGM Plates (Nematode Growth Media) 
To a flask, 1.5 g of NaCl, 1.25 g of BactoPeptone (Difco), 8 g of BactoAgar (Difco), and 
500 mL of ddH20 were added and autoclaved to sterilize the reagents.  Additional reagents of 
12.5 mL of 1M K3PO4 pH 6.0, 0.5 mL of CaCl2, 0.5mL of MgSO4, and 0.5 mL of 5 mg/mL 
Cholesterol were added to the autoclaved NGM solution.  NGM media was poured by hand into 
60 mm x 15 mm medium plates and allowed to solidify at room temp prior to long term storage 
in 4°C. 
For NGM Carbenicillin Plates, 1 mL of 50 mg/mL filter sterilized carbenicillin was 
added to the autoclaved 0.5 L of NGM media prior to pouring into 60 mm x 15 mm plates to 
bring the final concentration of carbenicillin at 0.1 mg/mL. 
 
Gels for western 
Reagents 7.5% Acrylamide Resolving 
Gel 
3.9% Acrylamide Stacking 
Gel 
30% acrylamide/0.8% 
bisacrylamide  
2 mL 0.52 mL 
4X Tris-HCl/SDS pH 8.8 2 mL N/A 
4X Tris-HCl/SDS pH 6.8 N/A 1 mL 
ddH20 4 mL 2.48 mL 
10% APS 30 uL 14 uL 
TEMED 6 uL 4 uL 
 
 
M9 Buffer 
 M9 consisted of 3 g KH"PO+, 6	g	Na"HPO+, 5	g	NaCl, 1	mL	1M	MgSO+, and H20 to 1 
litre. 
1X Transfer Buffer 
 1X Transfer Buffer consisted of 50 mL of 10X Transfer Buffer (15.2 g of Tris, 72.1 g of 
Glycine, 5.0 g of SDS, and ddH20 to 500 mL), 150 mL of methanol, and 300 mL of ddH20. 
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Knockdown Studies of PNPase in C. elegans 
 
 The goal for the knockdown studies of decreased expression of PNPase was to confirm 
previous results, expand the findings, and observe how they compared to overexpression and 
mutant studies of PNPase.  
 
PNPase Expression 
 Knockdown of PNPase was generated through an RNAi clone (Exon 3), that spanned the 
region from 5` of exon 1 through exon 3.  Previously knockdown of PNPase through RNAi 
resulted in a 63% reduction of mRNA and a 58% reduction in protein levels (Lambert 2015). 
PNPase expression was measured using a qRT-PCR protocol for PNPase expression at the exon 
9 and exon 10 junction.  Six replicate qRT-PCRs were performed to measure PNPase expression 
and the fold change results are listed as follows: Exon 3 (a) produced 0.36x (64% reduction), 
Exon 3 (b) produced 1.44x (44% increase), Exon 3 (c) produced 1.03x (3% increase), Exon 3 (d) 
produced 0.25x (75% reduction), Exon 3 (e) produced 1.03x (3% increase), and Exon 3(f) 
produced 0.74x (26% reduction) (Figure 31).   Worms from samples a, d, and f were used for 
measuring polycistronic transcript accumulation for Figure 33.  The results from this experiment 
identified issues with the knockdown model that required troubleshooting.  
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Figure 31: pnpt-1 expression of Knockdown Samples.  Exon 3 knockdown produced 
inconsistent knockdown results: (a) 0.36x (64% reduction), (b) 1.44x (44% increase), (c) 1.03x 
(3% increase), (d) 0.25x (75% reduction), (e) 1.03x (3% increase), and (f) 0.74x (26% 
reduction). L4440 served as the empty vector control (n=6) 
 
 
Polycistronic Transcript Accumulation 
Previous work with PNPase knockdown samples resulted in an increased trend in 
polycistronic transcripts with knockdown of PNPase expression (Lambert 2015).  The goal was 
to verify previous results after confirming samples had decreased expression of PNPase through 
RNAi.  qRT-PCR for PNPase expression determined knockdown of PNPase expression prior to 
measuring polycistronic transcript accumulation with a statistically significant 45X fold change 
in Exon 3 (55% knockdown) (p = 0.02) (Figure 32).  Knockdown samples used for measuring 
both PNPase expression and polycistronic transcript accumulation included knockdown samples 
a, d, f.  Polycistronic transcript accumulation was quantified using qRT-PCR protocols that 
measured expression using primers that amplified the ctb-1 and COIII junction.  Exon 3, 
knockdown of PNPase, resulted in a decreased trend for polycistronic transcripts with an 86.1% 
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decrease compared to L4440 control (Figure 33).  Statistical analysis could not be carried out 
since technical difficulties limited this experiment to two working attempts with samples a and d. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32: PNPase Expression in Knockdown Samples a, d, f.  Exon 3 knockdown results in a 
0.45x (55% decrease) fold change in PNPase expression.(p = 0.02) (n=3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33: Knockdown of PNPase. Exon 3 knockdown (Samples a and d) results in a decrease 
trend for polycistronic transcript accumulation. (n=2) 
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Total Mitochondrial Transcripts 
 Total mitochondrial transcripts were quantified using qRT-PCR by measuring the 
expression of COIII.  The COIII gene was used since it includes the ctb-1 and COIII junction 
that was used to quantify the polycistronic transcripts.  Knockdown of PNPase resulted in a 
decrease trend in total mitochondrial transcripts with a 37% decrease compared to the L4440 
control.  Due to technical issues with this experiment, the experiment was only conducted once 
and no statistical analysis could be carried out (Figure 34). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34: Total Mitochondrial Transcripts in Knockdown Animals. Knockdown of PNPase 
(Exon 3) produced a decreased trend in total mitochondrial transcripts. (n=1) 
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ROS Assay 
 Previous work studying knockdown of PNPase in C. elegans had identified a significant 
increase in ROS production (Lambert 2015).  To reconfirm the findings, ROS production was 
measured in both knockdown (Exon 3) and control (L4440) strains.  Knockdown of PNPase was 
initially confirmed through qRT-PCR prior to running the assay with two out of the three Exon 3 
samples showing decreased expression of PNPase (samples d and f).  Knockdown samples used 
for this assay consisted of samples d, e, and f.  As a result, Exon 3 presented a 0.67x fold change  
(32.5% decrease) in PNPase expression compared to L4440 control but was not statistically 
significant (p = 0.22) (n=3)(Figure 35).  Knockdown of PNPase (Exon 3) displayed an increased 
trend for ROS production compared to the control, matching previous results.  However, 
statistical analysis determined the result to be not significant (p = 0.20) (n=3)(Figure 36). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35: PNPase expression in RNAi strains associated with ROS Assay.  Exon 3, 
knockdown of PNPase, shows a decreased trend for PNPase expression but was determined to be 
non-significant (p = 0.22) (n=3)   
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Figure 36: ROS Production in Knockdown Animals. Knockdown of PNPase (Exon 3) showed 
no difference in ROS production compared to the control (L4440) (p = 0.20)(n=3) 
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Figure 37: Total PNPase Expression of all 3 expression profiles of PNPase 
  
   
 
135 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38: Polycistronic Transcript Accumulation from all 3 expression profiles of PNPase.  
(Knockdown samples, Exon 3 and L4440, were obtained from RNAi samples of ROS Assay and 
RNAi trouble shooting experiments.)(n=3) 
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Figure 39:  Total Mitchondrial Transcripts from all 3 expression profiles.  (n=1) 
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Figure 40: ROS Assay for all 3 expression profiles of PNPase (n=3) 
 
 
 
 
 
 
